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ACRONYMS AND ABBREVIATION 
 
Ac  
AcOH 
Alloc 
Acetyl  
Acetic acid 
Allyloxycarbamoyl 
Bn 
Cbz 
Benzyl 
Carbobenzyloxy 
DBU  Diazobicycloundecene  
DCM  Dichloromethane  
DMAP  Dimethylaminopyridine  
DMF  
DMM 
Dimethylformamide  
Dimethylmaloyl 
DMP  
EA 
Dess-Martin periodinane  
Ethyl Acetate 
Et  Ethyl  
IBX  Iodoxybenzoyc Acid  
Me  
Nap 
Methyl  
Naphthyilmethyl 
Ph  Phenyl  
Py  Pyridine  
RT  Room temperature  
PTSA  
PDT 
Para toluenesulfonic acid  
Propanedithiol 
T  Temperature  
TBAF  Tert butyl ammonium 
fluoride  
TBDMS  Tert butyl dimethyl silyl  
Tf  Trifluoromethansulfonyl 
TDS  Textyl dimethyl silyl  
TEMPO  Tetramethylpiperidinyloxyl  
THF  Tetrahydrofuran  
TMSOTf  Trimethylsilyltriflate  
Tol  
 
Toluene 
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Immune system 
The immune system is a network of biological structures and processes within an 
organism, with a protective function against disease-causing agents such as 
bacteria, viruses and parasites. It plays an important role in identifying and 
eliminating abnormal cells, including cancer cells. Fundamental are specialized 
cells, called antigen-presenting cells (APCs), which have the aim to display the 
antigen to lymphocytes and collaborate with them in the response to the antigen. 
Dendritic cells are a particular class of APCs, being responsible for the uptake of 
foreign antigens. Antigens include any molecule perceived by the immune system 
as foreign invader or simply potentially dangerous for the host. 
Antigens that elicit immune responses are termed immunogens, usually they are 
protein. Not all antigens are naturally immunogenic. Small, non-immunogenic 
antigens are called haptens and must be coupled to larger immunogenic molecules, 
termed carriers, to stimulate a response. Large protein antigens usually contain 
epitopes equivalent to carriers and haptens and are therefore inherently 
immunogenic. Carbohydrates, by contrast, must often be coupled to proteins in 
order to be immunogenic, as is the case for the polysaccharide antigens used in the 
Haemophilus influenza type b vaccine. 
There are two fundamentally different types of responses to invading microbes. 
The first line of defense is an immediate, rapid response called innate immune 
response which consists of all the immune defenses that lack immunologic 
memory. It defends the host from infection by other organism in a non-specific 
manner, so the innate system recognize and respond to pathogens in a generic way 
and it does not confer long-lasting or protective immunity to the host. Thus, a 
characteristic of innate responses is that they remain unchanged the antigen is 
encountered. 
The other type of immunological response is due to the adaptive immune system, 
also known as the acquired immune system. It is slower to develop, but manifests 
an increased antigenic specificity and memory. The innate immune response makes 
a crucial contribution to the activation of adaptive immunity. 
13 
 
The molecular components of innate responses include complement, acute-phase 
proteins, and cytokines such as the interferons. The cellular components of this 
system include dendritic cells (DCs), macrophages, natural killer cells and 
granulocytes as basophils, eosinophils and neutrophils. The innate system responds 
to pathogen associated molecular patterns (PAMPs), which are compounds 
structurally and chemically different presents in pathogens, through stimulation of 
various pattern-recognition receptors (PRRs). Toll-like receptor (TLRs) are a class 
of PRRs which recognize a huge variety of PAMPs. They activate the maturation 
process of DCs, and involve production of cytokines and chemokines which are 
protein or glycoprotein able to modify and activate the cells involved in the 
immune response. This process allow the pro-inflammatory context essential for T-
cells activation-differentiation and initiation of the adaptive (antigen-specific) 
immune response. When DCs encounter an antigen they undergo a transformation, 
being activated. They migrate in the draining lymph nodes where are present T-
cells, which are activated by modified DCs, leading to the process that allows the 
onset of the immune response. Acquired responses involve the proliferation of 
antigen-specific B and T cells, which occurs when the surface receptors of these 
cells bind to antigen. The initial stages of lymphocyte development do not require 
the presence of an antigen, but once these cells express a mature antigen receptor, 
their survival and further differentiation become antigen-dependent. 
The cells involved in the acquired immune system are T and B lymphocytes which 
are a subset of leukocyte. B cells and T cells are the major types of lymphocytes. 
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Fig. 1 
When DCs encounter the antigen,they are able to process it, complexing with 
particular molecules called MHC (major-histocompatibility complex), present on 
the surface of DCs, which expressed the antigens to T-cells and ensure the 
recognition from them. 
The crucial event of the T-cells activation - differentiation process is the 
immunological synapse, initiated by formation of a ternary complex MHC-antigen-
T-cells receptor (TCR on T cell surface, followed by further specific interactions. 
If the antigen is presenting by class II MHC, helper T-cells are activated (Th or 
CD4+). Class I MHC activated cytotoxic T-cells (CD8+ or CTL). Helper T-cells are 
fundamental to lead B lymphocytes to differentiate in memory cells or in plasma 
cells. B cells secrete immunoglobulins, the antigen-specific antibodies responsible 
for eliminating extracellular microorganisms. T cells help B cells to make antibody 
and can also eradicate intracellular pathogens by activating macrophages and by 
killing virally infected cells. While plasma cells produce low affinity IgM-type 
antibodies, which give an effective but short lasting response, memory cells enable 
a quantitatively and qualitatively superior secondary immune response to be 
mounted after a subsequent encounter with the same antigen, producing specific 
immunoglobulin (IgG antibodies). To allow this process of installation of 
immunological memory, the antigen has to be T-dependent, so produce B-memory 
cells through the interaction with Th-cells (MHC-II interaction). This kind of 
antigens are usually protein. Regarding T-independent antigens, they are able to 
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interact directly with B-cells, inducing an immunological response without the 
interaction with macrophages or T-cells. Without this cooperation is not possible 
the formation of memory cells. This process results in a lack of production of new 
memory B cells and a depletion of the memory B-cell pool, such that subsequent 
immune responses are decreased. Polysaccharides or proteic subunits usually found 
on the external coating of bacterial cells (capsule, flagella...) are example of T-
independent antigens. 
Antibodies recognizing an antigen don't interact and don't identify the entire 
molecule, but a specific portion of the surface called antigenic determinant or 
epitope. 
The concept of vaccination is based on the fact that deliberate exposure to a 
harmless version of a pathogen generates memory cells but not the pathologic 
sequelae of the infectious agent itself. In this way, the immune system is primed to 
mount a secondary immune response with strong and immediate protection should 
the pathogenic version of the microorganism be encountered in the future.
1
 
 
Fig. 2 
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Carbohydrates and immunology 
Carbohydrates have been established as the most abundant – and arguably the most 
structural diverse – organic molecules found in nature. In contrast with proteins and 
nucleic acids, whose biological relevance has a longstanding reputation, 
carbohydrates have been considered always as poor-information and repetitive 
macromolecules with only structural functions. Only recently they have been 
recognized to play a crucial rule in biological recognition processes (e.g. bacterial 
and viral infection, cancer metastasis and inflammatory reactions). It’s well known 
that oligosaccharides and glycoconjugates appear in all cells in different form, in 
particular they are present on the external layer. They can be found as peptido- and 
proteoglycans, glycoproteins, nucleic acids, lipopolysaccharides, or glycolipids. 
They dominate the landscape of the cell and are responsible for cell-cell 
interaction, the recognition of virus and bacteria, binding of toxins and are involved 
in cell growth, cell differentiation and cell motility. Depending on the type of 
bacterium carbohydrates may occur in the cell in different forms. Gram-positive 
bacteria possess a thick cell wall containing many layers of peptidoglycan and 
teichoic acids. In contrast, Gram-negative bacteria have a relatively thin cell wall 
consisting of a few layers of peptidoglycan surrounded by a second lipid membrane 
containing lipopolysaccharides (LPS) and lipoproteins which face into the external 
environment. As lipopolysaccharides are highly charged, the Gram negative cell 
wall has an overall negative charge. LPS of Gram-negative bacteria consists of 
three distinct structural components: species-specific repeating units of a 
polysaccharide (the O antigen); a conserved polysaccharide core with a glycosidic 
linkage to the O antigen; and an immunogenic component with a ketosidic linkage 
to the polysaccharide core (lipid A) The chemical structure of the outer membrane 
lipopolysaccharides is often unique to specific bacterial strains and is responsible 
for many of the antigenic properties of these strains. Moreover both Gram positive 
and negative bacteria could possess an additional polysaccharide coating called 
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capsule. It was demonstrated to be essential for the pathogenicity exerting a 
protective function against the host’s immune defence. 
 
Figura 3 
The exposure of carbohydrates on cells’surface enables them to interact with the 
immune system, acting as cell antigenic determinants. These features make 
carbohydrates attractive candidates as vaccine targets. 
Polysaccharide antigens are mostly poor immunogens due to their B-lymphocyte 
independent (TI) nature. Often, anti-polysaccharide immune response is 
characterised by lack of T-lymphocyte memory, isotype restriction and delayed 
ontogeny. Children below 2 years of age and elderly respond poorly to 
polysaccharide antigens. 
The conjugation of polysaccharides to proteins seems to allow carbohydrate-
specific responses that elicit T-cell help, and this technique has been harnessed to 
improve the efficacy of vaccines. 
In 1929 Avery and Goebel published an article in which they described that low 
molecular weight carbohydrates, similar to capsular bacterial polysaccharides 
epitopes (immunodeterminant portions) were able to stimulate the immune system 
through the production of specific antibodies, after the conjugation to a protein.
2
 
Glycoconjugate vaccines have proven to be effective in the treatment of various 
diseases, caused by different kind of bacteria: Haemophilus influenzae type b, 
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Streptococcus pneumoniae (of the vaccine serotypes) and Neisseria meningitidis. 
The current understanding of the activation of the adaptive immune system by 
glycoconjugate vaccines is based on research with haptens conjugated to carrier 
proteins. The traditional explanation for the mechanism of induction of 
polysaccharide-specific antibodies by glycoconjugates is that these vaccines 
generate T cell help through several steps. Polysaccharide-protein conjugates bind 
to the B cell receptor (BCR) of polysaccharide-specific pre-B cells and are taken 
into the endosome. Once inside the cell, the protein portion is digested by proteases 
to release peptide epitopes, which bind to MHCII by replacing the self-peptide. The 
peptide from the vaccine carrier protein is presented to the αβ receptor of CD4+ T 
cells in the context of the MHCII molecule. Peptide/MHCII-activated T cells 
release cytokines to stimulate B cell maturation and induce immunoglobulin class 
switching from IgM to polysaccharide-specific IgG (Fig. 4). 
 
Fig. 4 
Current conjugation chemistry requires polysaccharide modifications (e.g., random 
oxidation of the sugar chain) that alter natural epitopes, with consequent generation 
of low-affinity antibodies to the native polysaccharide. In addition, random 
conjugation between activated groups along the length of multiple repeating units 
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of a polysaccharide and random active sites on a protein (e.g., all lysine residues) is 
difficult to reproduce from batch to batch in a clinical vaccine preparation. 
The empirical observation that covalent linkage of glycan to protein is important 
for their immunological activities has prompted in the last two decades 
carbohydrate chemists to synthesize oligosaccharides, which are relatively short in 
length in comparison to native polymers, mimicking the surface carbohydrates of 
different pathogens, and couple them to carrier protein. These studies have allowed 
to identify the minimal structural requirements for raising functional antibodies of 
a variety of microbial polysaccharides. Such minimal functional epitopes can be, in 
certain cases, even oligosaccharides as short as hexa-, tetra-,or even disaccharide. 
To overcome the problems correlated to the preparation of glycoconjugate vaccines 
different methodologies have been investigated in recent years. One method is the 
achievement of  glycoconjugate by chemically controlled coupling of the 
saccharide CPSs to carriers through their reducing ends via linker molecules. These 
conjugates have proven valuable not only as new vaccine candidates for clinical 
use but also as molecular probes used in the mapping of antigenic determinants of 
bacterial polysaccharide (to optimize vaccine configuration) and in studies of the 
molecular mechanisms of antibody and cellular responses to conjugate vaccines. 
A second strategy, thanks to the development of carbohydrate chemistry, is the 
preparation of carbohydrate-based vaccine through the chemical synthesis. The 
vaccine against Haemophilus influenzae type b licensed in Cuba in 2003 is the first 
example of this new kind of vaccine.
3
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Acinetobacter baumannii 
Acinetobacter baumannii is a nonfermentative Gram-negative cocco bacillus, 
isolated from soil and water which represent its natural habitats. 
  
Fig. 5 
It has emerged as one of the most troublesome pathogens for health care 
institutions globally, especially it is an important cause of nosocomial infections. 
This pathogen affects notably patients receiving mechanical ventilation, patients 
sustaining burns or trauma, and in surgical-site infections. 
 
Fig. 6 
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The organism commonly targets the most vulnerable hospitalized patients, those 
who are critically ill with breaches in skin integrity and airway protection. Hospital 
acquired pneumonia is still the most common infection caused by this organism. 
However, in more recent times, infections involving the central nervous system, 
skin soft tissue, and bone have emerged as highly problematic for certain 
institutions. Furthermore A. baumannii has more recently caused a range of 
infectious syndromes in military personnel injured in the Iraq, Kuwait and 
Afghanistan conflicts, and this earned to it the name of “iraqibacteria”. 
As other nosocomial pathogens like Pseudomonas aeruginosa, Clostridium 
difficile, Escherichia coli and Staphylococcus aureus the clinical significance of A. 
baumannii has been propelled over the last 15 years for its remarkable ability to 
rapidly develop antibiotic resistance. Strains of this bacterium have demonstrated 
resistance to all known antibiotics. Acting in synergy with this emerging resistance 
profile is the uncanny ability of A. baumannii to survive for extended periods on 
environmental surfaces is notorious and is likely important for transmission within 
the health care setting. Multidrug resistance is common with health care-associated 
A. baumannii infections. The impressive number of acquired mechanisms of 
resistance makes selection of an appropriate empirical antimicrobial agent 
exceedingly difficult. Degradation enzymes against β-lactams, modification 
enzymes against aminoglycosides, altered binding sites for quinolones, and a 
variety of efflux mechanisms and changes in outer membrane proteins have been 
reported. Essentially, any and all of these elements can be combined to result in a 
highly drug-resistant, and at times panresistant, opportunistic pathogen. The 
consequences of these features are the increase of morbidity and mortality, as well 
an increased medical costs, indeed special procedure and isolation are required for 
patients wound by this pathogen. Here are shown the factors leading to the 
emergence and transmission of multidrug-resistant (MDR) Acinetobacter species.
4
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Fig. 7 
In Fig.8 are highlighted countries that have reported an outbreak of carbapenem-
resistant Acinetobacter baumannii. Red color signifies outbreaks reported before 
2006, and yellow signifies outbreaks reported since 2006. It can be noticed a 
broadcast of the infection due to this pathogen. This demonstrates why the attention 
of the biomedical research on this emerging bacterium is increased during recent 
years. Therefore there is an effort to find a solution for the treatment and the 
prevention of disease caused by this pathogen.
5
 
 
Fig. 8 
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Vaccine against Acinetobacter baumannii 
Due to the difficulty in treating infections caused by multi-drug resistant A. 
baumannii through an antibiotic therapy, novel approaches are needed for the 
prevention of the disease induced by this pathogen. Targeted vaccination of 
individuals at risk could represents an effective and cost-efficient strategy to 
prevent outbreaks. Therefore, a broadly protective vaccine against A. baumannii 
may have a major impact on some high risk groups, including ICU patients, injured 
military personnel, patients undergoing elective surgery, diabetics and hemodialysis 
patients. 
Despite these trends, no vaccines or antibody-based treatments for A. baumannii 
infections is currently on the market. The development of a vaccine for A. 
baumannii is complicated by the fact that no protective bacterial antigens have 
been identified and few virulence factors for this organism have been 
characterized.
6
 Moreover the presence of different serotype of this bacterium 
makes the development of a specific vaccine a challenging task. Therefore, a 
rational research program was undertaken to identify a candidate antigen for an A. 
baumannii vaccine. Antigen discovery was based on identification of the 
immunodominant targets from A. baumannii membrane protein preparations 
following systemic infection. In this framework, during recent years different 
research group started to study different methodologies for the immunization 
against this bacterium. 
The research group of Dr Michael McConnell exploited an inactivated whole cell 
(IWC), therefore (a classical approach), for active and passive immunization 
against A. baumannii in murine models. However the use of inactivated whole cells 
as a vaccine antigen may raise potential safety concerns over the possibility of 
incomplete inactivation.
7
 
For this reason the same group investigated the use of outer membrane vesicles 
(OMVs) as a vaccine in a mouse model of disseminated sepsis. The use of OMVs 
avoids related to IWC, as they are non-viable particles and bacterial cells are 
24 
 
removed by filtration during the purification process. This approach produces a 
robust, protective immune response.
8
 
That study, while promising, has the limitation of the undefined nature of the 
vaccine formulation and therefore the reproducibility on a large-scale preparation. 
Outer membrane protein (OmpA) was identified as a promising candidate for 
active and passive immunization based on humoral immunodominance during 
infection in mice.  
A. baumannii OmpA has been found to have a variety of interesting biological 
properties in in vitro model systems. For example, OmpA has been shown to bind 
to eukaryotic cells, translocate to the nucleus, and induce cell death. The research 
group of B. Spellberg isolated outer membrane protein of A. baumannii as 
antigenic material, and found that this material can be employed for active and 
passive immunization to prevent A. baumannii infections, but with this 
methodology only a single A. baumannii strain was evaluated, which limits the 
interpretation of these findings.
9
 
In recent years different research group investigated other kind of candidates for a 
vaccine against this pathogen, as biofilm associated protein (Bap), and trimeric 
autotransporter protein (Ata), which are specific cell surface protein directly 
involved in biofilm formation of the bacterium. The authors argue that the 
remarkable capacity to acquire antimicrobial resistance is attributable to its biofilm 
formation ability.
10
 
However, until now, these studies were conducted in vitro or in mouse model, so 
the formulation of a vaccine against A. baumannii still remains under investigation. 
25 
 
Bibliography 
1
Peter J.Dalves, and Ivan M. Roitt, The New England Journal of Medicine, 2000, 343, N.1 
2
 O.T. Avery, W. F. Goebel, J. Exp. Med. 1929, 50 (4), 533-550 
3
 a) Fikri Y. Avci and Dennis L. Kasper, Annu. Rev. Immunol. 2010, 28, 107-130; b) Sarkis 
K. Mazmanian and Dennis L. Kasper, Nature Review Immunology, 2006, 8, 849-858; c) 
Andrej Weintraub, Carbohydrate Research, 2003, 338 2539-2547; d) Francesco Berti and 
Roberto Adamo Chem. Biol. 2013, 8, 1653−1663 
4
 Lenie Dijkshoorn, Alexandr Nemec, Harald Seifert, Nature Review Microbiology 2007, 5, 
939-951 
5
 Anton Y. Peleg, Harald Seifert and David L. Paterson, Clin. Microbiol. Rev. 2008, 
21(3):538 
6
 Danilo G. Moriel, Scott A. Beatson, Daniël J. Wurpel, Jeffrey Lipman, Graeme R. 
Nimmo, David, L. Paterson, Mark A. Schembri, PlosOne 2013, 8, 10 
7
 Michael J. McConnell, Jerónimo Pachón, Vaccine, 2011, 29, 1-5 
8
 Michael J. McConnell, Carlos Rumbo, Germán Bou, Jerónimo Pachón, Vaccine, 2011, 29, 
5705-5710 
9
 a) Guanpingshen Luo, Lin Lin, Ashraf S. Ibrahim, Beverlie Baquir, Paul Pantapalangkoor, 
Robert A. Bonomo, Yohei Doi, Mark D. Adams, Thomas A. Russo, Brad Spellberg, 
PlosOne 2012, 7, 1; b) Federico Perez, Andrea M. Hujer, Kristine M. Hujer, Brooke K. 
Decker, Philip N. Rather and Robert A. Bonomo, Antimicrob. Agents Chemother. 2007, 51, 
3471-3484 
10
 a) Yaser Fattahiana, Iraj Rasoolia, Seyed Latif Mousavi Gargaria, Mohammad Reza 
Rahbara, Shakiba Darvish Alipour Astaneha, Jafar Amani, Microbial Pathogenesis 2011, 
51, 402-406; b) Leticia V. Bentancor, Abhisek Routray, Cagla Bozkurt-Guzel, Ana 
Camacho-Peiro, Gerald B. Pier, Tomás Maira-Litrán, Infection and Immunity, 2012, 80 
3381–3388 
 
 
 
                                                 
 
 
 
 
 
 
 
 
 
 
26 
 
 
 
 
 
 
RESULTS AND 
DISCUSSION 
 
 
 
27 
 
 
 
 
 
 
 
 
28 
 
Aim of the work 
In the framework of the synthesis of a candidate for a carbohydrate based vaccine 
against Acinetobacter baumannii we focused our attention on the virulent strain 
ATCC 17961. 
In 2009 Vinogradov and coworkers identified the pentasaccharide reported in Fig.1 
as the repeating unit of the O-chain of the LPS belonging to this strain.
1
 The 
peculiarities of this structure are the presence of a rare monosaccharide unit, 
namely 2,3-diacetamido-2,3-dideoxy-D-glucuronic acid (D) and a tetraglycosidated 
galactoside (C). Since unusual saccharide and branched portions within pathogen-
associated surface polysaccharides have usually strong antigenic properties and 
they are often essential components of the protective epitope, we focused our 
attention on three different fragments of the surface pentasaccharide, all of them 
containing the uncommon diacetamido residue D. 
 
Fig. 1 
The aim of this project is the synthesis of three fragments of the surface 
pentasaccharide of Acinetobacter baumannii ATCC 17961: the monomer D, the 
disaccharide C-D and the branched trisaccharide C-D-E (Fig 2). 
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Fig. 2 
The retrosynthetic approach is based on commercially available compounds such 
as glucosamine hydrochloride and α-methyl galactopyranoside. The retrosynthesis 
of the trisaccharide C-D-E is outlined in Scheme 1. Starting from glucosamine 
hydrochloride and α-methyl galactopyranoside. The crucial issues of the synthetic 
plan are the use of a N-participating protecting group to ensure the formation of β 
glycosidic bonds, a double inversion at C-3 to introduce two acetamido functions 
in trans-diequatorial arrangement for the synthesis of fragment D and exploit an 
orthogonal protection in at C-4 in the galactosyl moiety. 
 
Scheme 1 
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The dimethylmaleimide (DMM) which ensures the exclusive formation of 1,2-trans 
glycosidic bonds has been employed as a participating protecting group of the 
amine, (Fig.3). 
 
Fig. 3 
A naphthylmethylether (Nap) orthogonal to benzyl ether and that can be easily 
cleaved by an oxidative treatment with DDQ, was installed at position 4 of the 
galactoside. 
The same intermediates were used for the synthesis of the other two target 
compounds use. The monomer was obtained from the 2,3-“diamino” glycosyl 
donor 16, while for the synthesis of the disaccharide. It was necessary to provide 
the acceptor with an orthogonal group in position 4 (Scheme 2). 
 
 
Scheme 2 
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Synthetic strategy 
Synthesis of 2,3 “diamino” glycosyl donor 16 
In a first attempt, a synthetic route able to provid in large scale glycosil donor 16, 
(Fig. 4) precursor of the fragment D of the three compounds, was developed. 
 
Fig. 4 
Starting from the commercially available D-glucosamine hydrochloride, the amino 
group was protected as dimethylmaleimide (DMM), using dimethylmaleic 
anhydride and TEA in a 1.0M solution of EtONa in EtOH. Without any further 
purification, positions 4 and 6 were protected as benzylidene acetal with 
benzaldehyde dimethylacetal, PTSA in CH3CN at 40°C, giving compound 2 in 
70% yield over two steps. Exploiting the higher reactivity of the anomeric 
hydroxyl, it was selectively silylated with tert-butyldimethylsilyl chloride and 
imidazole giving compound 3 in 84% yield (Scheme 3). 
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Scheme 3 
Epimerization at the C-3 
A crucial issue of the synthetic strategy was the introduction of a nitrogen 
functionality in position 3 in equatorial configuration. For this purpose it was 
necessary to perform a double inversion at this position The first step was the 
epimerization of C-3 to give the alloside 5, then a SN2 displacement with a suitable 
nucleophile as an azide furnished the 2-3 “diamino” compound 12 (Scheme 4). 
 
Scheme 4 
In this case the first inversion of the hydroxyl was proved very challenging, so 
different methods described in the literature were investigated. 
Oxidation of the equatorial alcohol, followed by the reduction of the corresponding 
ketone is a widely used method for epimerization of alcohols. 
Oxidation with 2-iodoxybenzoic acid (IBX) in refluxing ethyl acetate gave 4 in 
60% yield.
2
 Better results were obtained performing the reaction using Dess-Martin 
periodinane (DMP) in dichloromethane, which gave ketone 4 in 90% yield. 
(Scheme 5).
3
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Scheme 5 
These two oxidizing agents are commercially available, but due to their high cost, 
they were synthesized starting from a cheap starting material such as 2-
Iodobenzoyc acid, and simple reagents as Oxone
®
, Ac2O and PTSA. IBX can be 
obtained in 85% yield, while DMP with a 75% overall yield (Scheme 6).
4
 
 
Scheme 6 
The reduction of ketone 4 with NaBH4 at room temperature or at 0°C led to the 
degradation of the molecule, due to the instability of the DMM group under 
reductive conditions. 
The use of a milder reducing agent as NaBH3(CN) in acidic conditions allowed to 
obtain only trace of alloside 5, with a large amount of byproducts.
5
 
Only a reduction under carefully controlled conditions: using NaBH4 in 
DCM:MeOH = 1:1, at -10°C, with a short  and strictly controlled reaction time: 
(210s) led to the desired compound 5 in satisfactory yield (83%), without 
significant degradation (Scheme 7).
6
 
 
Scheme 7 
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The inversion of configuration was checked by NMR. The chemical shift of some 
significant signal change, as the H-1 of the alloside compound 5 shifts to lower 
fields. Moreover the pattern of the some signal change. H-4 in the equatorial 
alcohol 3 is a pseudo-triplet while in the axial alcohol is a doublet of doublet, with 
a coupling constant between H-4 and H-3 of 2.4, in agreement with a cis constant. 
(Fig.5). 
 
Fig. 5 
Before the optimization of this procedure other methods were investigated to invert 
the configuration of the OH. 
The Lattrel-Dax reaction is a nitrite-mediated substitution of a triflate, to achieve 
the OH in the opposite configuration.
7
 This method performed on this substrate 
gave poor results in terms of yield: 25% in 2 steps. Whereas the synthesis of the 
triflate 6 is almost quantitative, major issues were found in the reaction with 
NaNO2 giving a complex mixture of compounds. (Scheme 8). 
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Scheme 8 
We reasoned that the poor reactivity of triflate 6 could be due to the strain of the 
molecule. We therefore decided to remove first the benzylidene acetal by 
regioselective opening with Et3SiH and PhBCl2 (88% yield). The primary OH was 
then selectively acetylated, with AcCl and collydine at low temperature, and the 
epimerization was attempted via triflate on alcohol. Under the same conditions 
used for 3 this substrate gave also a large amount of byproducts, and only 20% 
yield of the desired product 9 (Scheme 9). 
Scheme 9 
These results are in agreement with recent studies carried out on this reaction with 
differently protected sugars. In these works is highlighted that the presence of an 
ester, as an acetate or a benzoyl group near the hydroxyl which will be reversed, is 
crucial to have good results. The presence of benzyl ether and benzylidene 
negatively affects the results of the reaction as in 8 and 3.
8
 
Another method for the epimerization can be performed via mesylate. The 
formation of this intermediate with mesyl chloride and DIPEA gave 10 in 85% 
yield. The inversion at C-3 can be achieved by sodium acetate in 2-methoxyethanol 
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and water at reflux. Also in this case, after 24 h under these harsh conditions, the 
mesylate was recovered unchanged. (Scheme 10).
9
 
 
Scheme 10 
A very useful, and widely used reaction to invert the configuration of a free OH 
with a suitable nucleophile is the Mitsunobu reaction, performed with PPh3, DIAD 
and a nucleophile. Although para nitro benzoic acid is a good nucleophile, because 
it can be easily cleaved with TEA., glucoside 3 resulted unreact. The reaction was 
performed changing different parameters, such as solvent, temperature, order of 
addition of the reagents, but the starting material was always recovered unchanged, 
and product 11 was never observed. (Scheme 11).
10
 
 
Scheme 11 
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Once we obtained the alloside compound 5 in satisfactory yield through the 
oxidation-reduction protocol, the synthesis proceeded with the introduction of an 
amino functionality at position 3 in equatorial configuration. Starting from 5, first 
the free OH was converted in a good leaving group as the triflate with triflic 
anhydride and pyridine. The reaction of this rather unstable intermediate with NaN3 
in moist DMF at 60°C gave compound 12 in 62% yield over two steps (Scheme 
12). 
 
Scheme 12 
To introduce the azide we also tried the Mitsunobu reaction with DPPA, DIAD and 
PPh3. As in the case of the equatorial alcohol 3, also this substrate demonstrated to 
be unreactive in this conditions.
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Regioselective reductive opening of the benzylidene acetal with Et3SiH and 
PhBCl2, followed by acetylation of the primary OH provided compound 14 in 91% 
yield over 2 steps.
12
 The anomeric hydroxyl was desilylated by treatment with 
TBAF 1.0 M in THF at -40°C to give 15 in 93% yield (Scheme 13). 
 
Scheme 13 
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Hemiacetal 15 was transformed the N-phenyl trifluoroacetimidate 16 by reaction 
with 2,2,2-trifluoro-N-phenylacetimidoyl chloride and Cs2CO3 as a base (99% 
yield). The choice of this glycosyl donor was due to the low yield observed in the 
synthesis of the corresponding trichloroacetimidate 17 with trichloroacetonitrile 
and DBU (54% yield, Scheme 14).
13
 
 
Scheme 14 
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Synthesis of monomer D 
For the synthesis of monomer D, glycosyl donor 16 was coupled with the 
commercially available 3-N-carbobenzyloxy-aminopropanol. This reaction was 
performed using TMSOTf as a promoter, and afforded protected monosaccharide 
18 in 94% yield. Thanks to the presence of a participating protecting group as 
DMM in position 2, only the β anomer was obtained. (Scheme 15). 
 
Scheme 15 
Transformation of the DMM protected compound into the corresponding N-acetyl 
derivative was carried out under the following conditions: compound 18 was 
treated with sodium hydroxide until disappearance of the starting material, then 
addition of hydrochloric acid up to pH = 5 gave the free amine in position 2 (19). 
Acetylation with acetic anhydride in pyridine led to the acetamide 20 (91% yield 
over 2 steps) (Scheme 16). 
 
Scheme 16 
The mechanism of DMM cleavage was illustrated by Schmidt and coworkers in 
1998 and it is outlined in Scheme 17. Hydroxide addition leads to ring-opened 
intermediate A, which in the presence of acid is in equilibrium with butenolide B. 
Protonation of the basic nitrogen atom of the amide acetal moiety C leads to 
generation of DMMA and free amine hydrochloride D which is then transformed 
into the N-acetyl derivative (Scheme 17).
14
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Scheme 17 
The second acetamide function was introduced via azide reduction with 1,3-
propanedithiol and TEA, and acetylation with acetic anhydride in pyridine. The 
2,3-diacetamido compound 21 was obtained in 91% yield over 2 steps (Scheme 
18).
15
 
 
Scheme 18 
The primary hydroxyl was deacetylated under Zemplen condition, and converted to 
carboxylic acid by a TEMPO mediated oxidation, followed by the addition of 
NaClO 13% aqueous solution, to give 22 In order to facilitate the purification via a 
flash chromatography, the acid was converted into the corresponding benzyl ester 
23 with BnBr and KF as a base in 81% yield over 3 steps. (Scheme 19). 
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Scheme 19 
Catalytic hydrogenation of 23 removed the benzylic protecting groups, and 
afforded the monosaccharide D; that is the first target molecule provided with a 
suitable linker in anomeric position (Scheme 20). 
Scheme 20 
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Synthesis of disaccharide C-D 
Disaccharide fragment C-D was obtained from coupling of glycosil donor 16 and a 
suitable galactoside acceptor. This was easily synthesized in three steps from 
commercially available methyl-α-galactopyranoside. In a first attempt, positions 4 
and 6 were protected as benzylidene acetal, then the free OH were benzylated 
obtaining 25 (85% yield over 2 steps). Regioselective reductive opening of the 
benzylidene carried out with Et3SiH and TfOH at -78°C afforded the glycosyl 
acceptor 26 in 82% yield (Scheme 16).12
 
 
Scheme 21 
Glycosylation of 26 with donor 16 in the presence of TMSOTf as a promoter 
provided the protected disaccharide 27 in 54% yield. (Scheme 17). 
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Scheme 22 
The subsequent steps of deprotection and oxidation were performed following the 
same conditions previously described for the synthesis of monosaccharide 25. First 
DMM group was removed and the free amine acetylated under standard condition. 
The azide was reduced with 1,3-propanedithiol and TEA and acetylated with acetic 
anhydride in pyridine, obtaining the diacetamido compound 29 (Scheme 23). 
 
Scheme 23 
Disaccharide 29 was deacetylated and oxidized to carboxylic acid 30 with TEMPO 
and NaClO 13% aqueous solution. The acidic functionality was converted in the 
corresponding benzyl ester 31 in order to facilitate the purification and the final 
hydrogenation led to disaccharide target molecule C-D (Scheme 24). 
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Scheme 24 
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Synthesis of trisaccharide C-D-E 
For the synthesis of the third target molecule it required the synthesis of a new 
galactosyl, bearing a protecting group at C-4 orthogonal to benzyl ether. For this 
goal the 2-naphtylmethil ether was chosen. 
The starting material was, also in this case, the methyl-α-D-galactpyranoside. The 
first step was the installation of a naphthylidene acetal to protect positions 4 and 6. 
This reaction was performed with naphthaldehyde dimethylacetl, easily 
synthesized from naphthaldehyde in 85% yield (Scheme 25).
16
 
 
Scheme 25 
Positions 2 and 3 were then benzylated, (95% yield over two steps) and the 
naphthylidene ring was regioselectively opened with BH3
.
THF and Cu(OTf)2 
affording acceptor 34 (81% yield Scheme 26).
17
 
 
Scheme 26 
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Furthermore it was synthesized glycosyl donor 38, precursor of fragment E of the 
trisaccharide. Starting from intermediate 2, the two hydroxyls were acetylated, then 
the anomeric position was selectively deprotected with methylamine in THF, 
providing hemiacetal 36 in 74% yield over two steps. Glycosyl donor 37 was 
achieved as N-phenyl trifluoroacetimidate in 70% yield (Scheme 27). 
 
Scheme 27 
The synthesis of 37 would be seemingly simpler from 3, by 3-OH acetylation 
followed by 1-O-desilylation. This route was avoided for practical reasons. The 
benzylation of the free OH using NaH caused the degradation of the DMM. 
Moreover, the acetylation and subsequent desylilation provided the desired 
hemiacetal in only 50% yield, with the presence of unexpected byproduct, due to 
the migration of the acetate in anomeric position (Scheme 28). Desilylation was 
performed employing different reagents and condition as TBAF at low temperature 
or HF in pyridine, but the results were always unsatisfactory (from 25 to 40% 
yield).
18
 
 
Scheme 28 
The coupling of 37 with 34 using TMSOTf as a promoter afforded disaccharide 40 
in 45% yield. Then Nap group was removed under oxidative condition, (DDQ) to 
provide disaccharide acceptor 41 in 80% yield (Scheme 29). 
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Scheme 29 
The condensation between disaccharide acceptor 41 with N-
phenyltrifloroacetimidate 16 furnished the protected trisaccharide 42 in 52% yield 
(Scheme 30). 
 
Scheme 30 
Before deprotection of the DMM group it was necessary to open the benzylidene 
ring , because the acidic conditions during the DMM removal could decompose the 
molecule. This step was carried out with TfOH and Et3SiH at -78°C, providing 43 
in 83% yield (Scheme 31). 
 
Scheme 31 
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Then the two DMM groups were removed under the conditions illustrated above, 
and the amines acetylated under standard condition giving 44 in 84% yield. The 
remaining azide was reduced with 1,3-propanedithiol and converted in the third 
acetamide function 45 in 80% yield (Scheme 32). 
 
Scheme 32 
Zemplen deacetylation removed both the acetates, but oxidation with TEMPO and 
NaClO to carboxylic acid is chemoselective involved and only the primary OH, so 
it is possible to obtain carboxylic acid 46 which was converted in the 
corresponding benzyl ester 47 in 79 % yield (Scheme 33). 
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Scheme 33 
The removal of benzyl ethers and esters by catalytic hydrogenation furnished the 
third target molecule, trisaccharide C-D-E, in quantitative yield (Scheme 34). 
 
Scheme 34 
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CONCLUSION & FUTURE WORKS 
Three different fragments of the LPS O-chain moiety of Acinetobacter baumannii 
ATCC 17961 were synthesized. All this molecule contain in their structure a rare 
sugar namely 2,3-diacetamido-2,3-dideoxy-D-glucoronic acid. 
The binding affinity of these fragments will be evaluated by competitive ELISA 
assay against the anti-LPS serum of Acinetobacter baumannii ATCC 17961 
antibody. 
The biological characterization of the synthetic compounds will be performed by 
Dr. Michael J. McConnell, from Unit of Infectious Disease, Microbiology, and 
Preventive Medicine, Institute of Biomedicine of Sevilla (IBiS). 
The synthesis of the three fragments provided with a suitable linker in order to 
allow the conjugation with a carrier protein will be another issue of this project.  
For this purpose it will be necessary to furnish the galactoside fragment with a 
spacer. Moreover the synthesis of the pentasaccharide will be another tool. Also in 
this case the attention is focus on this fragment. Furthermore the linker in anomeric 
position a study on the use of protecting group has be done. A stable protection in 
position 2 is required, as a benzyl ether, while positions have to be provided with 
orthogonal functions.  
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General experimental methods  
Thin Layer Chromatography  
Thin Layer Chromatography (TLC) and High Performance Thin Layer 
Chromatography (HPTLC) were performed on Merck precoated 60F254 plates 
(0.25 mm and 0.2 mm thickness, respectively). Reactions were always followed by 
TLC-analysis; compounds were visualized, when appropriate, by UV light (254 
nm) and always by spraying with:  
- Molybdic solution [21 g of (NH4)4Mo4O24, 1g of Ce(SO4)2, 31 mL of H2SO4 98%, 
970 mL water]; 
- Sulphuric acid [50 mL of H2SO4 98%, 450 mL of MeOH, 450 mL water]; 
- Ninhydrin [2.7g of 2,2-Dihydroxyindane-1,3-dione, 27 mL of AcOH, 900 mL of 
n-BuOH (or EtOH)]; 
with detection by charring at 200°C.  
 
Flash chromatography  
According to Still1 procedure, compounds were purified by flash chromatography, 
using Silica gel (SiO2, high-purity grade (Merck Grade 9385), pore size 60 Å, 230-
400 mesh particle size) by Sigma-Aldrich
®
. 
In some cases it was also used a flash purification system, Biotage
®
 SP1™:2 SP1 
means a single-column flash purification system [with Touch Logic Control™ and 
TLC-to-gradient feature designed to accelerate and simplify the purification 
process]. Available in sizes from 10 g to 340 g with standard (50 μm) silica, 
Biotage SNAP cartridges were used to purify our compounds. 
 
NMR analysis  
NMR spectra were recorded in a Bruker Avance 400 instrument (400, 101 MHz for 
1
H, 
13
C), and all were run at room temperature (298K) if not specified. The samples 
were prepared using deuterated solvents, as CDCl3, D2O, CD3OD and (CD3)2SO, 
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by Sigma-Aldrich
®
. 
Chemical shifts (δ) are reported in ppm scale and the coupling constants (J) in Hz. 
The chemical shift displacement is based on the residual proton in the solvent (e.g. 
the CHCl3, 0.01 % in 99.99 % CDCl3). The multiplicity of signals has been 
described as: s (singlet), d (doublet), t (triplet), m (multiplet), dd (doublet of 
doublets), dt (doublet of triplets). 
1H-NMR spectra were recorded for all the synthesized products. In the case of 
unknown structure, the characterization is here reported by 1H-NMR, 13C-NMR: 
the registration of bidimensional (2D-COSY, 2D-HETCOR) analyses was due to 
better assignment of peaks to the structure.  
In the case of a dimer we called ring-A the sugar coupled with the spacer and ring-
B the one at the non-reducing terminus. 
 
Mass analysis  
ESI mass were recorded in negative or positive modes on Jeol AX-505 and for high 
resolution on Q-TOF 
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4,6-O-Benzylidene-2-deoxy-2-dimethylmaleimido--D-glucopyranoside 
(1) 
 
D-Glucosamine hydrochloride (3.0 g, 13.91 mmol) was added to a sodium ethoxide 
solution (1.0 M in ethanol, 13.92 mL, 13.92 mmol). After 10 min, the mixture was 
treated with dimethylmaleic anhydride (0.88 g, 6.97 mmol) and stirred for 20 min. 
Triethylamine (1.4 mL, 13.91 mmol) was added and the reaction mixture was again 
treated with dimethylmaleic anhydride (0.88 g, 6.97 mmol). The reaction mixture 
was warmed to 60C with stirring for 1.5 h then dried well in vacuo. The crude will 
be used as such in the next step. 
The residue was dissolved in dry CH3CN (70 mL) then benzaldehyde 
dimethylacetal (0.32 g, 2.1 mmol, 0.32 mL) p-TsOH (0.028g, 0.14 mmol) were 
added. The solution was stirred at 40°C for 16 h then it was quenched by adding 
TEA until neutral pH and solvent removed in vacuo. The residue was purified by 
flash chromatography (n-hexane/ethyl acetate =1:1) to yield 1 (3.65g, 70%) as a 
yellow foam. - TLC (n-hexane/ethyl acetate =1:1): Rf = 0.29. - 
1
H NMR (400 
MHz, CDCl3): δ 7.65 – 7.34 (m, 5H, (Ph)), 5.59 (ss, 1H, CHPh), 5.30 (m, 1H, H-
1), 4.75 – 4.59 (m, 1H, H-3), 4.56 (d, J = 4.4 Hz, 1H, H-2), 4.40 (dd, J = 10.4, 4.8 
Hz, 1H, H-6), 4.29 (dd, J = 11.1, 3.5 Hz, 1H, H-4), 3.95 (dd, J = 10.5, 8.5 Hz, 1H, 
H-2), 3.81 (q, J = 9.8 Hz, 1H, H-6'), 3.71 – 3.52 (m, 2H, H-5, H-4), 3.18 (d, J = 8.5 
Hz, 1H, OH), 2.52 (d, J = 3.1 Hz, 1H), 2.48 (d, J = 3.2 Hz, 1H), 2.09 – 1.94 (m, 
1H). 
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tert-Butyldimethylsilyl 4,6-O-Benzylidene-2-deoxy-2-dimethylmaleimido--
D-glucopyranoside (2) 
 
1 (3.65 g, 9.73 mmol) and imidazole (1.32 g, 19,46 mmol) were dissolved in dry 
THF (50 mL) under N2 atmosphere. The solution was cooled at 0°C and tert-
butylchlorodimethylsilane (3.81 g, 25.29 mmol) was added. . After stirring at room 
temp for 24 h the reaction mixture was diluted with water (30 mL), then extracted 
with dichloromethane (2 x 50 mL). The organic phase were dried with sodium 
sulfate and the solvent evaporated in vacuo. The residue was purified by flash 
chromatography (n-hexane/ethyl acetate = 4:1 to 3:1) to yield 2 (3,70g, 78%) as a 
white foam. - TLC (n-hexane/ethyl acetate =7:3): Rf = 0.36. - [α]D = -32.2 (c=0.45, 
chloroform). - 
1
H NMR (400 MHz, CDCl3): δ 7.60 – 7.34 (m, 5H, Ph), 5.56 (s, 1H, 
CHPh), 5.33 (d, J = 8.1 Hz, 1H, H-1), 4.53 (dt, J = 15.2, 7.6 Hz, 1H, H-3), 4.38 – 
4.27 (m, 1H, H-6), 3.99 (dd, J = 10.7, 8.1 Hz, 1H, H-2), 3.89 – 3.76 (m, 1H, H-6'), 
3.67 – 3.49 (m, 2H, H-5, H-4), 1.98 (s, 6H, 2CH3 (NDMM)), 0.87 – 0.73 (m, 9H, 
SiC(CH3)3), 0.15 – 0.04 (s, 3H, Si(CH3)), 0.04 – -0.07 (s, 3H, Si(CH3)). - 
13
C NMR 
(100 MHz, CDCl3) δ 171.06 (2 CO (NDMM)), 137.24 (2 C-NDMM), 137.10 ( C 
(Ar)), 130.26 – 125.70 (C-Ph), 101.98 (CH-Ph), 94.04 (C-1), 82.39 (C-4), 68.75 
(C-6), 68.53 (C-3), 66.21 (C-5), 58.57 (C-2), 25.33 (t-Bu), 8.65 (CH3 (NDMM)), -
4.23 (Si-CH3), -5.61 (Si-CH3). - EI-MS (positive mode); m/z: 512.6 [M + Na]. 
 
58 
 
1,1,1-Triacetoxy-1,1-dihydro-1,2-benziodoxol-3(1H)-one 
 
Oxone (84.5 g, 137.5 mmol) was dissolved in a 1L flask, in water (456 mL). 2-
Iodobenzoic acid (15.5 g, 62.5 mmol) was added, and reaction heat at 80°C for 3h, 
observing the formation of a white suspension. The temperature was cooled down 
at RT, and the reaction was put in a ice bath for 1h with the formation of a white 
precipitate. 
The solid was filtered off, and washed with small portions of cold water (3 X 10 
mL) and cold acetone (3 X 10 mL). It was dried in vacuo for 1 night. 
IBX (2-iodoxybenzoic acid) was suspended in 62 mL of Ac2O, and a catalytic 
amount of PTSA was added (1% wt). The mixture was heated at 80°C for 3h, and 
the dissolution of the suspension was observed. The solution was cooled in an ice 
bath for 2h with the formation of a white solid. The cold mixture was filtered on 
Buckner, and washed with ether (5 x 5 mL). The resulting white crystalline solid ( 
18.00 g, 42,4 mmol 68% yield on two steps) was dried in vacuo and stored at -
20°C.  
The spectroscopic data were in agreement with those reported in literature.
1
 
 
                                                 
1
  Robert E. Ireland' and Longbin Liu, J. Org. Chem. 1993,58, 2899 
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tert-Butyldimethylsilyl 4,6-O-Benzylidene-2-deoxy-2-dimethylmaleimido--
D-glucopyran-3-uloside (3) 
 
2 (3,70 g, 7,58mmol) was dissolved  in dry DCM (70 mL) under N2 atmosphere. A 
solution of DMP (6.42g, 15.16 mmol) in dry DCM (50 mL) was added dropwise, 
and stirred for 24h at room temperature. After completion of the reaction a 5% 
solution of thiosulfate (50 mL) was added and the mixture let stirred for 10' until 
two distinct phases were established. The organic layer was separated and washed 
with a saturated solution of NaHCO3 (50 mL), and water (50 mL). The organic 
phase was dried with sodium sulfate and the solvent evaporated in vacuo. The 
residue was purified by flash chromatography (n-hexane/ethyl acetate = 4:1) to 
yield 3 (3,32g, 90%) as a white foam. - TLC (n-hexane/ethyl acetate =7:3): Rf = 
0.68. - 1H NMR (400 MHz, CDCl3): δ 7.63 – 7.33 (m, 5H, Ph), 5.58 (ss, 2H, 
CHPh; H-1), 4.70 (dd, J = 7.3, 1.3 Hz, 1H, H-2), 4.50 (dd, J = 10.2, 4.6 Hz, 1H, H-
6), 4.37 (dd, J = 9.8, 1.3 Hz, 1H, H-4), 3.96 (t, J = 10.1 Hz, 1H, H-6'), 3.92 – 3.84 
(m, 1H, H-5), 2.01 (s, 6H, 2 CH3 (NDMM)), 0.85 (s, 9H, SiC(CH3)3), 0.13 (s, 3H, 
Si(CH3)), 0.04 (s, 3H, Si(CH3)). - 
13
C NMR (100 MHz, CDCl3) δ 192.31 (C-3), 
171.00 (2 CO (NDMM)), 137.67 ( 2 C-(NDMM)), 136.38 (C-(Ar)), 127.64 (Ph), 
102.08 (CHPh), 96.02 (C-1), 81.95 (C-4), 69.16 (C-6), 66.03 (C-5), 63.25 (C-2), 
25.30 (tBu), 8.74 (CH3 (NDMM)), -4.40 (Si-CH3), -5.53 (Si-CH3). - HRMS-Q-
TOF (positive mode); m/z: 510.1586 [M + Na] 
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tert-Butyldimethylsilyl 4,6-O-Benzylidene-2-deoxy-2-dimethylmaleimido--
D-allopyranoside (4) 
 
To a solution of 3 (3.32g, 6.82 mmol) in dry DCM:MeOH=1:1 (20 mL: 20 mL), 
under N2 atmosphere, cooled at -10°C was added in one portion NaBH4 (283mg, 
7.5 mmol). The reaction was maintained under vigorous stirring for 210s, thus was 
added a saturated solution of NH4Cl (10 mL) and acetone (10 mL). The reaction 
was stirred for 10 min, diluted with brine (30 mL) and extracted  with DCM (3 x 50 
mL). The organic phase were separated, dried with sodium sulfate and the solvent 
evaporated in vacuo. The residue was purified by flash chromatography (n-
hexane/ethyl acetate = 4:1) to yield 4 (2.77g, 83%) as a white foam. - TLC (n-
hexane/ethyl acetate =7:3): Rf = 0.47. - 1H NMR (400 MHz, CDCl3): δ 7.60 – 7.34 
(m, 5H, Ph), 5.84 (d, J = 8.3 Hz, 1H, H-1), 5.60 (s, 1H, CHPh), 4.42 – 4.29 (m, 2H, 
H-3, H-6 ), 4.25 (td, J = 9.9, 5.1 Hz, 1H, H-5), 4.10 (dd, J = 8.2, 2.3 Hz, 1H, H-2), 
3.82 (t, J = 10.3 Hz, 1H, H-6'), 3.77 (dd, J = 9.4, 2.4 Hz, 1H, H-4), 2.00 (s, 6H, 
2CH3 (NDMM)), 0.79 (s, 9H, SiC(CH3)3), 0.11 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3). 
- 
13
C NMR (100 MHz, CDCl3) δ 171.00 (CO (NDMM)), 137.39(C-(NDMM)), 
136.33 (C-Ar), 129.44, 128.32, 126.32 (Ph), 102.65 (CH-Ph), 91.01 (C-1), 84.87 
(C-3), 76.17 (C-4), 69.58 (C-6), 64.10 (C-5), 54.98 (C-2), 25.38 (tBu), 8.83 (CH3-
NDMM), -4.08 (Si-CH3), -5.55 (Si-CH3). - HRMS-Q-TOF (positive mode); m/z: 
512.1528 [M + Na] 
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tert-Butyldimethylsilyl 4,6-O-Benzylidene-2,3-dideoxy-3-azido-2-
dimethylmaleimido--D-glucopyranoside (5) 
 
4 (2.77g, 5.66 mmol) was dissolved in dry DCM (25 mL) under N2 atmosphere. 
Pyridine (1.37 mL, 16.98 mmol) was added and the solution was let stir at RT for 
15'. The reaction was cooled at 0°C and triflic anhydride (1.43 mL, 8.49 mmol) 
was dropped. After 1.5 h the solution was diluted with DCM (20 mL), and washed 
with HCl 5% (30 mL), a saturated solution of NaHCO3 (30 mL) and water (30 
mL). The organic phase was dried with sodium sulfate and the solvent evaporated 
in vacuo. The crude was let for 2 h in vacuo, then dissolved in humid DMF (30 
mL). NaN3 (1.1 g, 16.98 mmol) was added and the reaction let stir at 60°C over 
night. The solvent was removed under reduced pressure, the residue redissolved in 
DCM (40 mL) and washed with water (20 mL). The organic phase were dried with 
sodium sulfate and the solvent evaporated in vacuo. The residue was purified by 
flash chromatography (n-hexane/ethyl acetate = 9:1) to yield 5 (1.89g, 65%) as a 
white foam. - TLC (n-hexane/ethyl acetate =7:3): Rf = 0.59. - 1H NMR (400 MHz, 
CDCl3): δ 7.66 – 7.34 (m, 5H, Ph), 5.63 (s, 1H, CHPh), 5.30 (d, J = 8.0 Hz, 1H, H-
1), 4.52 (dd, J = 11.2, 9.1 Hz, 1H, H-3), 4.37 (dd, J = 10.5, 4.5 Hz, 1H, H-6), 3.94 
– 3.78 (m, 2H, H-2,H-6'), 3.78 – 3.58 (m, 1H, H-4,H-5), 1.99 (s, 6H, 2CH3 
(NDMM)), 0.81 (s, 9H, SiC(CH3)3), 0.08 (s, 3H, Si(CH3)), 0.00 (s, 3H, Si(CH3)). - 
13
C NMR (100 MHz, CDCl3) δ 178.06 (CO (NDMM)), 137.43 (C-(NDMM)), 
136.71 (C-Ar), 129.08, 128.28, 126.01, (Ph) 101.46 (CH-Ph), 94.14 (C-1), 81.07 
(C-4), 68.76 (C-6), 67.28 (C-5), 59.62 (C-3), 56.66 (C-2), 25.28 (tBu), 8.68 (CH3-
NDMM), -4.26 (2 Si-CH3). - HRMS-Q-TOF (positive mode); m/z: 537.1710 [M + 
Na]. 
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tert-Butyldimethylsilyl 6-O-acetyl-4-O-benzyl-2,3-dideoxy-3-azido-2-
dimethylmaleimido--D-glucopyranoside (6) 
 
5 (1.89 g, 3.68 mmol) was dissolved in dry DCM (20 mL) under N2 atmosphere. 
4Å MS (5.00 g) were added and stir for 40' at RT. Et3SiH (2.19 mL, 13.98 mmol) 
was added, the solution cooled at -78°C and PhBCl2 (525 μL, 4.42 mmol) was 
added dropwise. After 10' the reaction was quenched with TEA until neutral pH, 
and filtered on celite pad. The solvent was removed under reduced pressure, the 
residue redissolved in DCM (30 mL) washed with a saturated solution of NaHCO3 
(20 mL) and water (20 mL). The organic phase was dried with sodium sulfate and 
the solvent removed in vacuo. 
The crude was dissolved in dry DCM (20 mL) under N2 atmosphere. Pyridine (1.2 
mL, 14.72 mmol), acetic anhydride (695 μL, 6.44 mmol) and a catalytic amount of 
DMAP were added. After 2h the reaction was diluted with DCM (20 mL), and 
washed successively with HCl 5% (20 mL), a saturated solution of NaHCO3 (20 
mL) and water (20 mL). The organic phase was dried with sodium sulfate and the 
solvent evaporated in vacuo. The residue was purified by flash chromatography (n-
hexane/ethyl acetate = 9:1) to yield 6 (1.87g, 91%) as a white foam. - TLC (n-
hexane/ethyl acetate =9:1): Rf = 0.43. - 1H NMR (400 MHz, CDCl3): δ 7.51 – 7.20 
(m, 5H, Ph), 5.20 (d, J = 8.0 Hz, 1H, H-1), 4.87 (d, J = 10.8 Hz, 1H, CH2Ph), 4.62 
(d, J = 10.8 Hz, 1H, CH2Ph), 4.38 (ddd, J = 17.9, 10.3, 5.7 Hz, 2H, H-6, H-3), 4.19 
(dd, J = 11.8, 5.6 Hz, 1H, H-6'), 3.82 (dd, J = 11.6, 8.0 Hz, 1H, H-2), 3.70 (ddd, J = 
9.7, 5.6, 2.3 Hz, 1H, H-5), 3.46 (t, J = 9.4 Hz, 1H, H-4), 2.08 (s, 3H, CH3CO), 2.00 
(s, 6H, 2CH3 (NDMM)), 0.78 (s, 9H, SiC(CH3)3), 0.05 (s, 3H, Si(CH3)), 0.00 (s, 
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3H, Si(CH3)).- 
13
C NMR (100 MHz, CDCl3) δ 170.54 (2 CO (NDMM)), 137.47 
(C-NDMM), 136.96 (C-Ar), 128.58, 128.32, 128.25 (Ph), 93.52 (C-1), 77.85 (C-4), 
74.88 (CH2Ph), 73.83 (C-5), 63.29 (C-3), 62.84 (C-6), 56.53 (C-2), 25.31 (tBu), 
20.76 (CH3CO), 8.69 (2 CH3 (NDMM)), -4.31 (Si-CH3), -5.62 (Si-CH3). - EI-MS 
(positive mode); m/z: 581.7 [M + Na]. 
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6-O-acetyl-4-O-benzyl-2,3-dideoxy-3-azido-2-dimethylmaleimido-α/-D-
glucopyranoside (7) 
 
6 (1.87g, 3.35 mmol)was dissolved in dry THF (20 mL) under N2 atmosphere. The 
solution was cooled at -40°C and TBAF 1.0 M  in THF (5.02 mL, 5.02 mmol) was 
added dropwise and let stir for 2h. After completion of the reaction glacial acetic 
acid (100 μL, 1.67 mmol) was added, and the mixture warmed to r.t. The solution 
was diluted with brine (20 mL), and extracted with DCM (3 x 30 mL). The organic 
phase was separated, dried with sodium sulfate and solvent evaporated in vacuo. 
The residue was purified by flash chromatography (n-hexane/ethyl acetate = 1:1) to 
yield 7 (1.38g, 93%) as a white solid. - TLC (n-hexane/ethyl acetate =1:1): Rf = 
0.38. - 1H NMR (400 MHz, CDCl3) δ 7.37 (m, 5H, Ph), 5.21 (m, 2H, H-1-α/), 
4.93 – 4.78 (m, 2H, CHPh, H-3α), 4.61 (dd, J = 10.6, 4.3 Hz, 1H, CHPh), 4.49 – 
4.34 (m, 2H, H-3), 4.25 (m, 2H, H-6', H-5), 4.05 (m, 1H, H-2α), 3.82 – 3.68 
(m, 2H, H-2, H-5), 3.51 (m, 1H, H-4α/), 2.99 (d, J = 7.0 Hz, 1H, OH), 2.10 (ss, 
3H, CH3CO), 2.01 (ss, 6H, 2 CH3 (NDMM)). - 
13
C NMR (100 MHz, CDCl3) δ 
170.54 (2 CO (NDMM)), 137.47 (C-NDMM), 136.96 (C-Ar),129.31, 129.08, (Ph) 
93.77 (C-1), 78.49 (C-4), 75.69 (CH2Ph), 74.69 (C-5), 63.60 (C-3), 63.23 (C-6), 
56.56 (C-2), 21.57 (CH3CO), 9.55 (2 CH3 (NDMM)). -  EI-MS (positive mode); 
m/z: 467.4 [M + Na]. 
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6-O-acetyl-4-O-benzyl-2,3-dideoxy-3-azido-2-dimethylmaleimido-α/-D-
glucopyranosyl N-Phenyltrifluoroacetimidate (8) 
 
7 (1.38, 3.11 mmol) was dissolved in dry DCM (20 mL) under N2 atmosphere. The 
solution was cooled at 0°C in an ice bath. 2,2,2-trifluoro-N-phenylacetimidoyl 
chloride (755 μL, 4.66 mmol) and cesium carbonate (1.52 g, 4.66 mmol) were 
added  in sequence. The reaction was warmed to RT and stirred for 2h, then filtered 
on a celite pad and evaporated in vacuo. The residue was purified by flash 
chromatography (n-hexane/ethyl acetate = 9:1 + 1% TEA) to yield 8 (1.81g, 99%) 
as a white foam. - TLC (n-hexane/ethyl acetate =6:4): Rf = 0.66. 
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N-(Benzyloxycarbonyl)aminopropyl-6-O-acetyl-4-O-benzyl-2,3-dideoxy-3-
azido-2-dimethylmaleimido--D-glucopyranoside (9) 
 
8 (1.81 g, 3.07 mmol) and NHCbz-propanol (3.28 g, 15.35 mmol) were dissolved 
in dry DCM (20 mL) under N2 atmosphere. 4Å MS (5.00 g) were added and stir for 
40' at RT.  The mixture was cooled at -40°C and a solution 0.1 M of TMSOTf (3.07 
mL) in DCM was added dropwise. After 2h the reaction was quenched with TEA 
until neutral pH, than filtered on celite pad. The solvent was removed under 
reduced pressure. The residue was purified by flash chromatography (n-
hexane/ethyl acetate = 7:3) to yield 9 (1.77g, 91%) as a yellow oil. - TLC (n-
hexane/ethyl acetate =1:1): Rf = 0.56. - 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.24 
(m, 10H, Ph), 5.10 (s, 2H, CH2Ph(Cbz)), 5.01 (d, J = 8.4 Hz, 1H, H-1), 4.86 (d, J = 
10.7 Hz, 1H, CHPh), 4.61 (d, J = 10.7 Hz, 1H, CHPh), 4.44 (d, J = 11.7 Hz, 1H, H-
6), 4.30 (dd, J = 11.4, 9.3 Hz, 1H, H-3), 4.22 (dd, J = 12.0, 4.4 Hz, 1H, H-6'), 3.91 
– 3.77 (m, 2H, H-2, H-7), 3.67 (ddd, J = 9.6, 4.3, 2.2 Hz, 1H, H-5), 3.52 (ddd, J = 
18.9, 9.5, 7.3 Hz, 2H, H-7', H-4), 3.17 (dtt, J = 19.7, 13.2, 6.5 Hz, 2H, H-9, H-9'), 
2.06 (s, 3H, CH3CO), 2.00 (s, 6H, 2 CH3 (NDMM)), 1.78 – 1.61 (m, 2H, H-8, H-
8'). - 13C NMR (100 MHz, CDCl3) δ 170.61 (2 CO (NDMM)), 156.38 (CO 
(NHCbz), 137.61 (C-NDMM), 136.86 (C-Ar), 128.60, 128.48, 128.37, 128.31, 
128.07, 128.03 (Ph), 98.36 (C-1), 77.44 (C-4), 74.97 (CH2Ph), 73.86 (C-5), 66.97 
(C-7), 66.51 (CH2Ph (NHCbz), 63.56 (C-3), 62.49 (C-6), 54.26 (C-2), 37.90 (C-9), 
29.45 (C-8), 20.78 (CH3CO), 8.79 (2 CH3 (NDMM)). - HRMS-Q-TOF (positive 
mode); m/z: 658.2373 [M + Na] 
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N-(Benzyloxycarbonyl)aminopropyl-6-O-acetyl-4-O-benzyl-2,3-dideoxy-2-
acetamido-3-azido--D-glucopyranoside (10) 
 
9 (1.77 g, 2.79 mmol) was dissolved in a dioxane:H2O mixture (4:1, 10 mL), 
NaOH  powder (2.80 g, 69.7 mmol) was added and let stirred for 24h at RT. Than 
the pH was adjusted at 5 by adding 1.0M HCl, and the solution was stirred for 
other 24h. After completion of the reaction, it was neutralized with potassium 
carbonate and dried well in vacuo. The residue was treated with pyridine (20 mL), 
acetic anhydride (10 mL) and stirred at RT for 16h. The solution was co-evaporated 
with toluene in vacuo. The residue was dissolved DCM (30 mL), and washed 
successively with HCl 5% (20 mL), a saturated solution of NaHCO3 (20 mL), water 
(20 mL), dried over sodium sulfate and dried in vacuo. The residue was purified by 
flash chromatography (toluene/ethyl acetate = 6:4) to yield 10 (1.25g, 79%) as a 
yellow oil. - TLC (n-hexane/ethyl acetate =1:1): Rf = 0.27. - 1H NMR (400 MHz, 
CDCl3) δ 7.49 – 7.16 (m, 10H, Ph), 6.52 (d, J = 7.8 Hz, 1H, NHAc), 5.20 – 5.08 
(m, 2H, CH2Ph (Cbz)), 5.05 (s, 1H, NHCbz), 4.88 (d, J = 10.8 Hz, 1H, CHPh), 
4.59 (d, J = 10.8 Hz, 1H, CHPh), 4.49 (d, J = 8.2 Hz, 1H, H-1), 4.36 (dd, J = 11.9, 
1.7 Hz, 1H, H-6), 4.20 (dd, J = 12.0, 4.5 Hz, 1H, H-6'), 3.98 – 3.88 (m, 1H, H-7), 
3.78 (t, J = 9.9 Hz, 1H, H-3), 3.54 (ddd, J = 13.8, 13.1, 6.1 Hz, 3H, H-2, H-5, H-9), 
3.47 – 3.34 (m, 2H, H-4, H-7'), 3.19 – 3.05 (m, 1H, H-9'), 2.05 (s, 3H, CH3CO), 
2.04 (s, 1H, CH3CO (NHAc)), 1.81 (ddd, J = 14.2, 9.5, 4.6 Hz, 1H, H-8), 1.65 (dd, 
J = 13.2, 9.1 Hz, 1H, H-8').
13
C NMR (100 MHz, CDCl3) δ 171.09 (COCH3-
NHAc), 170.62 (CH3CO-Ac), 156.79 (CO (NHCbz), 137.19 (C-Ar), 136.69 (C-
Ar), 128.60, 128.56, 128.31, 128.28, 128.19, 128.06 (Ph), 100.69 (C-1), 76.59 (C-
4), 74.83 (CH2Ph), 73.70 (C-5), 66.81 (CH2Ph (NHCbz),66.71 (C-7), 66.64 (C-3), 
62.74 (C-6), 55.49 (C-2), 37.33 (C-9), 29.74 (C-8), 23.25 (CH3CO (NHAc)), 20.79 
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(CH3CO). - HRMS-Q-TOF (positive mode); m/z: 592.2842 [M + Na]. 
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N-(Benzyloxycarbonyl)aminopropyl-6-O-acetyl-4-O-benzyl-2,3-dideoxy-2,3-
diacetamido--D-glucopyranoside (11) 
 
10 (1.25 g, 2.20 mmol) was dissolved in dry MeOH (15 mL) under N2 atmosphere. 
Triethylamine (890 μL, 6.60 mmol) and 1,3-propanedithiol (660 μL, 6.60 mmol) 
were added in sequence and the solution was stirred for 24h at RT. After 
completion of the reaction the solvent was removed in vacuo. The residue was 
treated in pyridine (15 mL) with acetic anhydride (10 mL) and stirred at RT for 
24h. The solution was coevaporated with toluene in vacuo. The residue was 
purified by flash chromatography (dichloromethane/methanol = 98:2) to yield 11 
(1.16g, 91%) as a yellow oil. - TLC (dichloromethane/methanol = 95:5): Rf =0.15 - 
1H NMR (400 MHz, CDCl3) δ 7.44 – 7.25 (m, 10H, Ph), 7.17 (d, J = 8.1 Hz, 1H, 
NHAc (2)), 6.33 (d, J = 8.8 Hz, 1H, NHAc (3)), 5.21 – 5.02 (m, 3H, CH2Ph, NH, 
(Cbz)), 4.57 (dd, J = 24.9, 11.1 Hz, 2H, CH2Ph), 4.35 (dd, J = 11.9, 1.9 Hz, 1H, H-
6), 4.23 (m, 2H, H-6', H-1), 4.15 (dd, J = 14.8, 5.5 Hz, 1H, H-3), 3.95 – 3.82 (m, 
2H, H-2, H-3), 3.65 – 3.49 (m, 2H, H-5, H-9), 3.42 (t, J = 9.4 Hz, 1H, H-4), 3.38 – 
3.29 (m, 1H, H-7'), 3.15 – 3.04 (m, 1H, H-9'), 2.06 (s, 3H, CH3CO), 1.97 (s, 3H, 
CH3CO (NHAc)), 1.92 (s, 3H, CH3CO (NHAc)), 1.78 (dd, J = 9.5, 5.1 Hz, 1H, H-
8), 1.60 (dd, J = 12.1, 8.0 Hz, 1H, H-8'). - 
13
C NMR (100 MHz, CDCl3) δ 171.96, 
171.40 (2 CO (NHAc), 170.65 (CO (CH3CO), 156.88 (CO (NHCbz), 137.48 (C-
Ar), 136.56 (C-Ar), 128.59, 128.53, 128.37, 128.20, 128.10 (Ph), 101.82 (C-1), 
76.53 (C-4), 74.39 (CH2Ph), 74.23 (C-5), 66.89 (CH2Ph (NHCbz)), 66.32 (C-7), 
63.16 (C-6), 56.03 (C-3), 54.13 (C-2), 36.96 (C-9), 29.86 (C-8), 23.37, 22.90 (2 
CH3CO (NHAc)), 20.83 (CH3CO). - ESI (positive mode); m/z: 608.6 [M + Na]. 
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Benzyl N-(Benzyloxycarbonyl)aminopropyl-4-O-benzyl-2,3-dideoxy-2,3-
diacetamido--D-glucopyranuronate (12) 
 
11 (1.16 g, 2.00 mmol) was dissolved in dry MeOH (10 mL) under N2 atmosphere. 
A catalytic amount of a solution 0.1M MeONa in MeOH was added, and after 1h 
the reaction was neutralized with Amberlite IR-120. The resin was filtered off, and 
solvent evaporated in vacuo. 
The crude was dissolved in acetone (15mL), and the solution was cooled at 0°C. 
Then were added successively: NaHCO3 5% in water (8.8 mL), KBr (475 mg, 4.00 
mmol) and TEMPO (437 mg, 2.80 mmol). After 10’ at 0°C NaClO 13% (0.74 mL) 
was added. After 30’ TLC analysis (DCM:MeOH=95:5) shown the disappearance 
of the starting material, and a spot at Rf=0. The solvent was removed in vacuo, co-
evaporated with toluene. 
The residue was redissolved in dry DMF (15 mL) under N2 atmosphere, and after 
the addition of KF (1.16 mg, 20 mmol) let stir for 5’ at 0°C. Then BnBr (1.18 mL, 
10 mmol) was added, letting warm at RT. After 16h. the solvent was removed in 
vacuo, the crude dissolved in DCM (20 mL) and washed with water (10 mL). The 
aqueous phase was extracted with DCM (3 X 10 mL). The combined organic layers 
were dried with sodium sulfate and evaporated in vacuo. The residue was purified 
by flash chromatography (dichloromethane/methanol = 98:2) to yield 12 (1.03g, 
80%) as a white solid. - TLC (dichloromethane/methanol = 95:5): Rf =0.28. - 
1
H 
NMR (400 MHz, CDCl3) δ 7.42 – 7.18 (m, 15H, Ph), 7.14 (d, J = 8.1 Hz, 1H, 
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NHAc (2)), 6.30 (d, J = 8.6 Hz, 1H, NHAc (3)), 5.18 (q, J = 12.3 Hz, 2H, CH2Ph 
(COOBn)), 5.11 (s, 3H, CH2Ph, NH (Cbz)), 4.56 – 4.44 (m, 2H, CH2Ph), 4.36 (d, 
J = 6.8 Hz, 1H, H-1), 4.26 – 4.08 (m, 2H, H-3, H-5), 3.94 (dd, J = 16.3, 7.4 Hz, 
2H, H-7, H-2), 3.82 (t, J = 8.0 Hz, 1H, H-4), 3.48 (dt, J = 17.4, 6.7 Hz, 1H, H-9), 
3.37 – 3.26 (m, 1H, H-7'), 3.17 – 3.02 (m, 1H, H-9'), 1.92 (s, 3H, CH3CO 
(NHAc)), 1.85 (s, 3H, CH3CO (NHAc)), 1.82 – 1.70 (m, 1H, H-8), 1.68 – 1.54 (m, 
1H, H-8'). - 
13
C NMR (100 MHz, CDCl3) δ 171.32, 170.94 (2 CO (NHAc)), 168.77 
(COOBn), 156.82 (CO (NHCbz)), 137.45, 136.59, 135.01 (3 C-Ar), 128.64, 
128.60, 128.56, 128.51, 128.44, 128.23, 128.18, 127.97 (Ph), 101.65 (C-1), 76.94 
(C-4), 75.08 (C-5), 73.79 (CH2Ph (NHCbz)), 67.36 (CH2Ph (COOBn)), 66.86 
(CH2Ph (NHCbz)), 66.62 (C-7), 53.40 (C-3), 52.52 (C-2), 37.02 (C-9), 29.78 (C-
8), 23.26, 22.94 (2 CH3CO (NHAc)). - HRMS-Q-TOF (positive mode); 
m/z:670.2637 [M + Na]. 
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Aminopropyl-2,3-dideoxy-2,3-diacetamido--D-glucopyranuronic acid (13) 
 
12 (1.03g, 1.6 mmol)was dissolved in MeOH:H2O=1:1 (5mL:5mL), and a catalytic 
amount of Pd/C was added. The solution was put under H2 atmosphere for 24h. The 
mixture was filtered off over a Celite pad and solvent removed under reduced 
pressure to yield 13 (0.53g, 100%) as a pale yellow solid. - 
1
H NMR (400 MHz, 
D2O) δ 4.63 (d, J = 8.4 Hz, 1H, H-1), 4.06 (d, J = 9.8 Hz, 1H, H-5), 4.00 – 3.87 (m, 
2H, H-3, H-7), 3.80 – 3.56 (m, 3H, H-7’, H-2, H-4), 3.02 (m,  2H, H-9, H-9’), 1.91 
(b, 8H, CH3CO (NHAc), H-8, H-8’). - 13C NMR (100 MHz, D2O) δ 174.88 (CO 
(NHAc)), 174.56 (CO (NHAc)), 172.33 (COOH), 101.42 (C-1), 75.68 (C-5), 69.60 
(C-4), 68.01 (C-7), 54.75 (C-3), 53.57 (C-2), 37.52 (C-9), 26.73 (C-8), 22.03 (2 
CH3CO (NHAc)). - HRMS-Q-TOF (positive mode); m/z: 356.1548 [M + Na]. 
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1
H-NMR compound 13 
 
13
C-NMR compound 13 
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Methyl 2,3-di-O-benzyl-4,6-O-Benzylidene-α-D-galactopyranoside (14) 
 
To a suspension of α-methyl galattose (1.00g, 5.2 mmol) in CH3CN (25 mL), 
benzaldehyde dimethyl acetale (1.2 mL, 7.8 mmol) and a catalytic amount of p-
toluenesulfonic acid were added. The reaction mixture was stirred at room 
temperature for 24h, then neutralized with TEA and evaporated in vacuo. The 
crude was purified by crystallization from ethyl acetate and n-hexane. 
This compound was dissolved in dry DMF (25mL) under N2 atmosphere BnBr 
(1.6mL, 13.5mmol) and TBAI (1.9g, 5.2mmol) were added. Then NaH (0.3g, 12.48 
mmol) was added in small portion ensuring that the solution doesn't heat. After 2h 
the reaction was quenched adding MeOH, and the solvent removed in vacuo. The 
residue was dissolved in DCM (50 mL) and washed with brine (2 X 30mL), dried 
and evaporated. The residue was purified by flash chromatography (n-hexane/ethyl 
acetate = 4:1) to yield 14 (2.36g, 98%) as a white solid. - TLC (n-hexane/ethyl 
acetate =1:1): Rf = 0.84. 
The spectroscopic data were in agreement with those reported in literature. 
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Methyl 2,3,4-tri-O-benzyl-α-D-galactopyranoside (15) 
 
14 (2.36g, 5.1 mmol) was dissolved in dry DCM (40mL) under N2 atmosphere. 3Å 
MS (3.0g) were added and stir for 40' at RT. Et3SiH (2.6mL, 16.32.mmol) was 
added, the solution cooled at -78°C and then TfOH (1.26 mL, 14.3 mmol) was 
added dropwise. After 2h the reaction was quenched adding TEA until neutral pH 
and filtered on celite pad. The solvent was removed under reduced pressure, the 
crude was redissolved in DCM (50mL) washed with a saturated solution of 
NaHCO3 (30mL) and water (30mL). The organic phase was dried with sodium 
sulfate and the solvent removed in vacuo. The residue was purified by flash 
chromatography (n-hexane/ethyl acetate = 4:1) to yield 15 as a yellow oil. (1.95g, 
82%). TLC (n-hexane/ethyl acetate =7:3): Rf = 0.51. 
The spectroscopic data were in agreement with those reported in literature. 
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Methyl 6-O-acetyl-4-O-benzyl-2,3-dideoxy-3-azido-2-dimethylmaleimido--
D-glucopyranosyl-(1 4)-2,3,6-tri-O-benzyl-α-D-galactopyranoside (16) 
 
A mixture of compound 8 (103 mg, 0.17 mmol) and compound 15 (65.7 mg, 0.14 
mmol) was dissolved in dry DCM ( 8 mL) under Argon atmosphere. 4Å molecular 
sieves (200 mg) were added, and the suspension was stirred for 40’ at RT. Then it 
was cooled at -20°C and a 0.1 M solution of TMSOTf (0.17 mL) was added 
dropwise. After 2h the reaction was quenched with TEA until neutral pH, than 
filtered on celite pad. The solvent was removed under reduced pressure. The 
residue was purified by flash chromatography (n-hexane/ethyl acetate = 4:1) to 
yield 16 (67mg, 54%) as a yellow oil. - TLC (n-hexane/ethyl acetate =7:3): Rf = 
0.34. - 1H NMR (400 MHz, CDCl3) δ 7.52 – 7.13 (m, 20H, Ph), 5.11 (d, J = 8.2 
Hz, 1H, H-1A), 4.88 (d, J = 10.6 Hz, 1H, CHPh), 4.68 – 4.52 (m, 6H, H-1B, H-3A, 
2 CHPh, CH2Ph), 4.50 (d, J = 2.9 Hz, 2H, CH2Ph), 4.44 (d, J = 11.5 Hz, 1H, 
CHPh), 4.39 – 4.30 (m, 1H, H-6A), 4.16 (dt, J = 14.3, 5.5 Hz, 1H, H-6A'), 3.92 (dt, 
J = 14.0, 7.1 Hz, 1H, H-2A), 3.79 – 3.66 (m, 2H, H-4B, H-5B), 3.66 – 3.44 (m, 6H, 
H-5A, H-4A, H-2B, H-3B, 2 H-6B, ), 3.33 (s, 3H, OCH3), 2.03 (s, 3H, CH3CO), 
1.85 (s, 6H, 2 CH3 (NDMM)). - 
13
C NMR (100 MHz, CDCl3) δ 170.38 (COCH3), 
156.60 (), 138.32 (), 128.61, 128.43, 127.87, 127.80, 127.58, 127.45, 127.25 (Ph), 
99.51(C-1A), 98.27 (C-1B), 77.54 - 77.18 (C-2B, C-3B, C-5A, C-4A), 74.90, 
77 
 
73.94, 73.43 (3 CH2Ph), 73.30 (C-5B), 73.09 (CH2Ph), 70.11 (C-6B), 69.13 (C-
4B), 62.98 (C-3A), 62.40 (C-6A), 55.19 (OCH3), 54.51 (C-2A), 20.77 (CH3CO), 
10.53 (2 CH3 (NDMM)). -- EI-MS (positive mode); m/z: .913.3 [M + Na]. 
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Methyl 6-O-acetyl-4-O-benzyl-2,3-dideoxy-2-acetamido-3-azido--D-
glucopyranosyl-(1 4)-2,3,6-tri-O-benzyl-α-D-galactopyranoside (17) 
 
16 (67 mg, 0.075 mmol)was dissolved in a dioxane:H2O mixture (4:1 = 10 ml), 
NaOH (75 mg, 1.88mmol)powder was added and let stirred for 24h at RT. Than the 
pH was adjusted at 5 by adding 1N HCl, and the solution was stirred for other 24h. 
After completion of the reaction, it was neutralized with potassium carbonate and 
the solvent evaporated in vacuo. The residue was treated in pyridine (5 mL) with 
acetic anhydride (0.5 mL, 4.8 mmol) and stirred at RT for 24h. The solution was 
co-evaporated with toluene in vacuo. The residue was purified by flash 
chromatography (n-hexane/ethyl acetate = 6:4) to yield 17 (35mg, 56%) as a 
yellow oil. - TLC (n-hexane/ethyl acetate =1:1): Rf = 0.47. - 
1
H NMR (400 MHz, 
CDCl3) δ 7.51 – 7.24 (m, 20H, Ph), 5.84 (d, J = 7.9 Hz, 1H, NHAc), 4.90 (dd, J = 
18.1, 10.3 Hz, 2H, 2 CHPh), 4.74 (m, 2H, H-1A, CHPh), 4.65 (dd, J = 10.9, 3.7 
Hz, 2H, 2 CHPh), 4.59 – 4.52 (m, 4H, 3 CHPh, H-1B), 4.36 – 4.27 (m, 1H, H-6A), 
4.14 (dd, J = 12.0, 3.4 Hz, 1H, H-6A'), 4.02 (d, J = 3.4 Hz, 1H, H-4B), 3.96 (m, 
2H, H-3B, H-5B), 3.85 – 3.76 (m, 2H, H-2A, H-2B), 3.76 – 3.65 (m, 1H, H-6B), 
3.65 – 3.52 (m, 1H, H-6B'), 3.45 – 3.40 (m, 2H, H-5A, H-4A), 3.39 (s, 3H, OCH3), 
3.18 (dd, J = 10.7, 9.1 Hz, 1H, H-3A), 2.11 (s, 3H, CH3CO (NHAc)), 2.01 (s, 3H 
(CH3CO)). - 
13
C NMR (100 MHz, CDCl3) δ 170.44 (COCH3 (NHAc)), 170.39 
(COCH3 (CH3CO)), 138.40, 138.12, 137.66, 137.06 (C-Ar), 128.99, 128.88, 
128.68, 128.62, 128.54, 128.36, 128.30, 128.00, 127.71, 127.56, 127.42 (Ph), 
102.56 (C-1B), 97.78 (C-1A), 77.78, 77.74, 77.67 (C-4B, C-2B, C-5B), 75.68 (C-
4), 75.04 (CH2Ph), 74.66 (CH2Ph), 74.15 (C-5A), 73.27, 72.97 (2 CH2Ph), 69.57 
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(C-6B), 68.87 (C-3B), 68.79 (C-3A), 62.41 (C-6A), 55.37 (OCH3), 54.37 (C-2A), 
23.01 (CH3CO (NHAc)), 20.74 (CH3CO). –ESI-MS (positive mode); m/z: 847.5 
[M + Na]. 
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Methyl 6-O-acetyl-4-O-benzyl-2,3-diacetamido-2,3-dideoxy--D-
glucopyranosyl-(1 4)-2,3,6-tri-O-benzyl-α-D-galactopyranoside (18) 
 
17 (35 mg, 0.042 mmol) was dissolved in dry MeOH (5 mL) under N2 atmosphere. 
Triethylamine (41microL, 0.3 mmol) and 1,3-propanedithiol (30 microL, 0.3 
mmol) were added in sequence and the solution warmed at 60°C for 24h. After 
completion of the reaction the solvent was removed in vacuo. The residue was 
treated in pyridine (5 mL) with acetic anhydride (0.273 mL, 2.7 mmol) and stirred 
at RT for 24h. The solution was co-evaporated with toluene in vacuo. The crude 
was purified by flash chromatography (DCM/MeOH 98:2) to yield 18 (23 mg, 
65%) as yellow oil. Rf = 0.74 (DCM:MeOH = 9:1). 
The residue was purified by flash chromatography (dichloromethane/methanol = 
98:2) to yield 18 (23mg, 65%) as a yellow oil. - TLC (dichloromethane/methanol 
=9:1): Rf =0.74. - 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.09 (m, 20H, Ph), 6.49 (d, 
J = 6.8 Hz, 1H, NHAc), 6.20 (d, J = 8.3 Hz, 1H, NHAc), 5.10 (d, J = 12.2 Hz, 1H, 
CHPh), 4.85 (t, J = 10.5 Hz, 2H, 2 CHPh), 4.78 – 4.67 (m, 4H, H-1A, H-1B, 2 
CHPh), 4.61 (d, J = 11.6 Hz, 1H, CHPh), 4.50 – 4.34 (m, 4H, 2 CHPh, H-1B, H-
6A), 4.13 – 4.06 (m, 2H, H-6A’, H-4B), 4.06 – 3.99 (m, 1H, H-3A), 3.97 (dd, J = 
9.9, 3.1 Hz, 1H, H-3B), 3.94 – 3.86 (m, 2H, H-2A, H-5B), 3.79 (dd, J = 9.8, 3.5 
Hz, 1H, H-2B), 3.74 (dd, J = 9.3, 7.0 Hz, 1H, H-6B), 3.67 (t, J = 9.2 Hz, 1H, H-
4A), 3.55 (dd, J = 9.3, 5.5 Hz, 1H, H-6B), 3.38 (s, 3H, OCH3), 1.82 (s, 3H, 
CH3CO (NHAc)), 1.56 (s, 3H, CH3CO (NHAc)), 1.28 (s, 3H, CH3CO). - 
13
C 
NMR (100 MHz, CDCl3) δ 170.44,  170.72 (COCH3 (NHAc)), 170.39 (COCH3 
(CH3CO)), 138.40, 138.12, 137.66, 137.06 (C-Ar), 128.99, 128.88, 128.68, 128.62, 
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128.54, 128.36, 128.30, 128.00, 127.71, 127.56, 127.42 (Ph), 102.56 (C-1B), 97.78 
(C-1A), 77.78, 77.74, 77.67 (C-4B, C-2B, C-5B), 75.68 (C-4), 75.04 (CH2Ph), 
74.66 (CH2Ph), 74.15 (C-5A), 73.27, 72.97 (2 CH2Ph), 69.57 (C-6B), 68.87 (C-
3B), 56.18 (C-3A), 62.41 (C-6A), 55.37 (OCH3), 54.37 (C-2A), 23.01, 22.55 
(CH3CO (NHAc)), 20.74 (CH3CO). – ESI-MS (positive mode); m/z: .863.7 [M + 
Na]. 
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Methyl (benzyl-(4-O-benzyl-2,3-diacetamido-2,3-dideoxy--D-
glucopyranosyluronate)-(1 4)-2,3,6-tri-O-benzyl-α-D-galactopyranoside 
(19) 
 
18 (23 mg, 0.027 mmol) was dissolved in dry MeOH (5 mL) under N2 atmosphere. 
A catalytic amount of a solution 0.1M of MeONa in MeOH was added, and after 
1h the reaction was neutralized with Amberlite IR-120. The resin was filtered off, 
and solvent evaporated in vacuo. 
The crude was dissolved in acetone (4 mL), and the solution was cooled at 0°C. 
Then were added in successively NaHCO3 5% (1.3 mL), KBr (6.5 mg, 0.05 mmol) 
and TEMPO (6.0 mg, 0.04 mmol). After 10’ at 0°C NaClO 13% solution (0.102 
mL) was added. After 3h a TLC (DCM:MeOH=95:5) shown the disappearance of 
the starting material, and a spot at Rf=0. The solvent was removed in vacuo, 
stripping with toluene. 
The crude was redissolved in dry DMF under N2 atmosphere and BnBr (28 microL, 
0.27 mmol) was added. The solution was cooled at 0°C, and KF (17 mg, 0.14 
mmol) was added, letting warmed at RT. After stirring for 16h, the solvent was 
removed in vacuo, the crude dissolved in DCM (5 mL) and washed with water (3 
mL). The aqueous phase was extracted with DCM (3 X 5 mL). The combined 
organic layers were separated, dried with sodium sulfate and evaporated in vacuo. 
The residue was purified by flash chromatography (dichloromethane/methanol = 
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98:2) to yield 19 (20mg, 81%) as a white solid. - TLC (dichloromethane/methanol 
=95:5): Rf =0.35. - 
1
H NMR (400 MHz, CDCl3) δ 7.62 – 7.06 (m, 25H, Ph), 6.50 
(d, J = 6.9 Hz, 1H, NHAc), 6.18 (d, J = 8.2 Hz, 1H, NHAc), 5.10 (d, J = 12.2 Hz, 
1H, CHPh), 4.85 (t, J = 10.6 Hz, 2H, 2 CHPh), 4.78 – 4.66 (m, 4H, H-1A, H-1B, 2 
CHPh), 4.61 (d, J = 11.6 Hz, 1H, CHPh), 4.47 (d, J = 11.7 Hz, 1H, CHPh), 4.45 (s, 
2H, CH2Ph ), 4.39 (d, J = 11.6 Hz, 1H, CHPh), 4.10 (dd, J = 9.0, 5.6 Hz, 2H, H-
4B, H-5A), 4.06 – 3.99 (m, 1H, H-3A), 3.97 (dd, J = 9.9, 3.1 Hz, 1H, H-3B), 3.94 
– 3.83 (m, 2H, H-2A, H-5B), 3.82 – 3.75 (m, 1H, H-2B), 3.75 – 3.70 (m, 1H, H-
6B), 3.67 (t, J = 9.2 Hz, 1H, H-4A), 3.55 (dd, J = 9.4, 5.5 Hz, 1H, H-6B), 3.37 (s, 
3H, OCH3), 1.82 (s, 3H, CH3CO), 1.56 (s, 3H, CH3CO). - 
13
C NMR (100 MHz, 
CDCl3) δ 171.41, 170.72 (COCH3 (NHAc), 168.31 (CO (COOBn)), 138.32, 
138.00, 137.40, 137.09, 134.86 (C-Ar), 129.14, 128.85, 128.57, 128.48, 128.43, 
128.39, 128.36, 128.03, 127.90, 127.75, 127.63, 127.59 (Ph), 103.40 (C-1B), 97.89 
(C-1A), 78.14 (C-4A), 78.04 (C-4B), 77.83 (C-2B), 77.68 (C-3B), 76.12 (C-5A), 
74.95, 74.21, 73.28, 73.15 (CH2Ph), 68.65 (C-6B), 68.42 (C-5B), 67.18 (CH2Ph 
(COOBn)), 56.18 (C-3A), 55.43 (OCH3), 53.59 (C-2A), 23.34, 22.55 (2 CH3CO 
(NHAc)). - -  EI-MS (positive mode); m/z: 925.9 [M + Na]. 
84 
 
Methyl-2,3-diacetamido-2,3-dideoxy--D-glucopyranosyluronic-(1 4)-α-
D-galactopyranoside (20) 
 
19 (19.7 mg, 0.021 mmol) was dissolved in MeOH:H2O=1:1 (6 mL), and a 
catalytic amount of Pd/C was added. The solution was put under H2 atmosphere for 
24h. The mixture was filtered over a Celite pad and solvent removed under reduced 
pressure to yield 20 (9.5mg, 100%) as a pale yellow solid.(NMR analysis acquired 
at 323K) - 
1
H NMR (400 MHz, D2O) δ 5.00 (dd, 2H, H-1A, H-1B), 4.37 (d, J = 2.6 
Hz, 1H, H-4B), 4.23 – 4.06 (m, 3H, H-3A, H-5A, H-5B), 4.06 – 3.94 (m, 3H, H-
6B, H-3B, H-2A), 3.93 – 3.76 (m, 3H, H-6B', H-2B, H-4A), 3.60 (s, 3H, OCH3), 
2.20 (s, 6H, 2 CH3CO (NHAc)). - 
13
C NMR (100 MHz, D2O) δ 134.32 (COOH), 
102.20 (C-1B), 99.69 (C-1A), 76.50 (C-4B), 70.29 (C-5A), 70.13 (C-5B), 69.51 
(C-3B), 68.63 (C-4A), 60.46 (C-6B), 55.37 (OCH3), 55.08 (C-3A), 54.09 (C-2A), 
22.26 (2 CH3CO (NHAc)). – ESI-MS (positive mode); m/z: .475.4 [M + Na]. 
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1
H-NMR compound 20 
 
13
C-NMR compound 20 
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3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-dimethylmaleimido--D-
glucopyranoside (21) 
 
1 (1.0g, 2.6 mmol) was dissolved in dry DCM (15mL) under N2 atmosphere. 
Pyridine (1.7 mL, 20.8 mmol), acetic anhydride (1.1 mL, 10.4 mmol) and a 
catalytic amount of DMAP were added. After 2h the reaction was diluted with 
DCM, and washed successively with HCl 5%, a saturated solution of NaHCO3 and 
water. The organic phase was dried with sodium sulfate and the solvent evaporated 
in vacuo. The residue was used in the next step. 
It was dissolved in dry THF (25 mL) under N2 atmosphere. A 2.0 M solution of 
NH2Me in MeOH was added (1.3 mL, 2.6 mmol). After 2h the starting material 
persist in the reaction mixture, so other 0.7 mL of NH2Me solution were added, 
letting stir overnight. The solvent was removed under reduced pressure and the 
residues redissolved in DCM (30mL). The organic layer was washed with a HCl 
5% (15mL), and water (15mL). The organic phase was dried with sodium sulfate 
and the solvent removed under reduced pressure. The residue was purified by flash 
chromatography (n-hexane/ethyl acetate = 7:3) to yield 21 (0.79g, 73%) as a 
yellow foam. - TLC (n-hexane/ethyl acetate =7:3): Rf = 0.25. 
The spectroscopic data were in agreement with those reported in literature.
2
 
                                                 
2
  Dusan Hesek, Mijoon Lee, Ken-ichiro Morio, and Shahriar Mobashery, J. Org. 
Chem. 2004, 69, 2137-2146 
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3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-dimethylmaleimido--D-
glucopyranoside N-Phenyltrifluoroacetimidate (22) 
 
21 (0.79g, 1.9 mmol) was dissolved in dry DCM (20 ml) under N2 atmosphere. The 
solution was cooled at 0°C in an ice bath. 2,2,2-trifluoro-N-phenylacetimidoyl 
chloride (0.46mL, 2.8 mmol) and cesium carbonate (0.91g, 2.8 mmol) were added  
in sequence. The reaction was warmed to RT and stirred for 2h, then filtered on a 
celite pad and evaporated in vacuo.  
The residue was purified by flash chromatography (n-hexane/ethyl acetate = 9:1+ 
1% TEA) to yield 22 (0.76g, 72%) as a yellow foam. - TLC (n-hexane/ethyl acetate 
=7:3): Rf = 0.40. 
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2-(dimethoxymethyl)naphthalene (23) 
 
To a solution of 2-naphthaldehyde (15.6 g, 0.10 mol) in dry methanol (30 mL) 
trimethyl-orthoformate (15.6 mL, 0.15 mol, 1.5 equiv) and a catalytic amount of 
PTSA were added. The mixture was let stir 24h. The mixture was diluted with 
DCM (500 mL) and was washed with satd. NaHCO3 solution (300mL) and water 
(300mL). The organic layer was dried and evaporated to yield 23 (18.1g, 0.09 mol) 
as a pale yellow oil. - TLC (n-hexane/ethyl acetate = 8:2): Rf = 0.67. 
The spectroscopic data were in agreement with those reported in literature.
3
 
                                                 
3
 A. Borbàs et al. Tetrahedron, 2002, 58, 5723-5732 
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Methyl 2,3-di-O-benzyl-4,6-O-(2 naphtyl) methylene α-D-galactopyranoside 
(24) 
 
To a suspension of α-methyl galattoside (1.0g, 5.2 mmol) in CH3CN (25mL), 2-
naphthaldehyde dimethyl acetale (1.57g, 7.8 mmol) and a catalytic amount of p-
toluenesulfonic acid were added. The reaction mixture was stirred at room 
temperature for 24h, then neutralized with TEA and evaporated in vacuo. The 
residue was purified by crystallization from ethyl acetate and n-hexane. 
This compound was dissolved in dry DMF (25mL) under N2 atmosphere BnBr 
(1.6mL, 13.5mmol) and TBAI (1.9g, 5.2mmol) were added. Then NaH (0.3g, 12.48 
mmol) was added in small portion ensuring that the solution doesn't heat. After 2h 
the reaction was quenched adding MeOH, and the solvent removed in vacuo. The 
residue was dissolved in DCM (50 mL) and washed with brine (2 X 30mL), dried 
and evaporated. The residue was purified by flash chromatography (n-hexane/ethyl 
acetate = 7:3) to yield 24 (2.53g, 95%) as a white solid. - TLC (n-hexane/ethyl 
acetate =1:1): Rf = 0.6. 
The spectroscopic data were in agreement with those reported in literature.
3
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Methyl 2,3-di-O-benzyl-4-O-(2-naphtyl) methyl α-D-galactopyranoside (25) 
 
24 (2.53g, 4.9 mmol) was dissolved in BH3
.
THF complex 2.0M solution (25mL) 
and cooled at 0°C. A catalytic amount of Cu(OTf)2:5% was added, the solution 
become dark. The temperature was allowed to warm at RT and let stir for 3h. The 
reaction was quenched with TEA and MeOH, and the solvent removed in vacuo. 
The residue was purified by flash chromatography (n-hexane/ethyl acetate = 1:1) to 
yield 25 (2.05g, 81%) as a colorless oil. - TLC (n-hexane/ethyl acetate =1:1): Rf = 
0.21 
The spectroscopic data were in agreement with those reported in literature.
3
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Methyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-dimethylmaleimido-
- D-glucopyranosyl-(1 6)-2,3-dibenzyl-4-O-(2-naphtyl) methyl α-D-
galactopyranoside(26) 
 
A mixture of compound 22 (114 mg, 0.2 mmol) and compound 25 (87 mg, 0.16 
mmol) was dissolved in dry DCM (10 ml) under Argon atmosphere. 4Å molecular 
sieves (200 mg) were added, and the suspension was stirred for 40’ at RT. Then it 
was cooled at -20°C and a 0.1 M solution of TMSOTf in DCM was added 
dropwise (0.2 mL). After 2h the reaction was quenched with TEA until neutral pH, 
than filtered on celite pad. The solvent was removed under reduced pressure. The 
residue was purified by flash chromatography (n-hexane/ethyl acetate = 7:3) to 
yield 26 (80mg, 53%) as a white foam. - TLC (n-hexane/ethyl acetate =7:3): Rf = 
0.15. - 
1
H NMR (400 MHz, CDCl3) δ 7.56 – 7.18 (m, 22H, Ph), 5.73 (t, J = 9.6 Hz, 
1H, H-3C), 5.53 (s, 1H, CHPh), 5.31 (d, J = 8.4 Hz, 1H, H-1C), 4.81 (d, J = 12.0 
Hz, 2H, 2 CHPh), 4.73 – 4.61 (m, 2H, 2 CHPh), 4.54 (d, J = 2.8 Hz, 1H, H-1B), 
4.44 – 4.33 (m, 1H, H-5B), 4.11 – 4.01 (m, 1H, H-2C), 4.01 – 3.93 (m, 1H, H-5C), 
3.82 (m, 4H, H-6B, H-6’B, H-6C, H-2B), 3.72 (m, 3H, H-4B, H-6’B, H-3B), 3.26 
(s, 3H, OCH3), 1.95 (ss, 9H, CH3CO, 2 CH3 (NDMM)). EI-MS (positive mode); 
m/z: 936.4[M + Na]. 
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Methyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-dimethylmaleimido--D-
glucopyranosyl-(1 6)-2,3-dibenzyl-α-D-galactopyranoside (27) 
 
To a solution of 27 (80 mg, 0.086 mmol) in dry DCM:MeOH=4:1 (2.5 mL:0.5 
mL), under N2 atmosphere, was added DDQ (freshly crystallized from chloroform) 
(30.mg, 0.12 .mmol). After 2h since the starting material didn't disappear, another 
portion of DDQ was added. (30.mg, 0.12 mmol). After 1h the reaction was diluted 
with DCM (10 mL), and washed with a saturated solution of NaHCO3 (3 X 10 
mL). Organic phases were dried on Na2SO4 and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography (n-
hexane/ethyl acetate = 6:4) to yield 27 (50.7mg, 80%) as a white foam. - TLC (n-
hexane/ethyl acetate =1:1): Rf = 0.42. - 
1
H NMR (400 MHz, CDCl3) δ 7.56 – 7.18 
(m, 15H, Ph), 5.73 (t, J = 9.6 Hz, 1H, H-3C), 5.53 (s, 1H, CHPh), 5.31 (d, J = 8.4 
Hz, 1H, H-1C), 4.81 (d, J = 12.0 Hz, 2H, 2 CHPh), 4.73 – 4.61 (m, 2H, 2 CHPh), 
4.54 (d, J = 2.8 Hz, 1H, H-1B), 4.44 – 4.33 (m, 1H, H-5B), 4.11 – 4.01 (m, 1H, H-
2C), 4.01 – 3.93 (m, 1H, H-5C), 3.82 (m, 4H, H-6B, H-6’B, H-6C, H-2B), 3.72 (m, 
3H, H-4B, H-6’B, H-3B), 3.26 (s, 3H, OCH3), 1.95 (ss, 9H, CH3CO, 2 CH3 
(NDMM)). EI-MS (positive mode); m/z: 796.3 [M + Na]. 
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Methyl 6-O-acetyl-4-O-benzyl-2,3-dideoxy-3-azido-2-dimethylmaleimido--
D-glucopyranosyl-(1 4)-3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-
dimethylmaleimido--D-glucopyranosyl-(1 6)-2,3-dibenzyl-α-D-
galactopyranoside (28) 
 
A mixture of compound 8 (0.203 g, 0.33 mmol) and compound 27 (208 mg,.27 
mmol) was dissolved in dry DCM (10 ml) under Argon atmosphere. 4Å molecular 
sieves (400.mg) were added, and the suspension was stirred for 40’ at RT. Then it 
was cooled at -20°C and a 0.1 M solution of TMSOTf in DCM (0.208 mL) was 
added dropwise. After 2h the reaction was quenched with TEA until neutral pH, 
than filtered on celite pad. The solvent was removed under reduced pressure. The 
residue was purified by flash chromatography (n-hexane/ethyl acetate = 6:4) to 
yield 28 (162 mg, 50%) as a white foam. - TLC (n-hexane/ethyl acetate =1:1): Rf = 
0.62. - 
1
H NMR (400 MHz, CDCl3) δ 7.52 – 7.30 (m, 20H, Ph), 5.80 – 5.70 (m, 
1H, H-3C), 5.52 (s, 1H, CHPh), 5.22 (d, J = 8.4 Hz, 1H, H-1C), 4.97 (d, J = 8.3 
Hz, 1H, H-1A), 4.90 (d, J = 10.7 Hz, 1H, CHPh), 4.68 (d, J = 10.7 Hz, 1H, CHPh), 
4.65 – 4.50 (m, 4H, H-6A, H-3A, CH2Ph), 4.42 (m, 3H, CHPh, H-1B, H-6C), 4.05 
(dd, J = 11.9, 3.7 Hz, 1H, H-6’A), 3.98 (dd, J = 10.2, 8.4 Hz, 1H, H-2C), 3.86 (dd, 
J = 11.5, 8.4 Hz, 1H, H-2A), 3.81 – 3.42 (m, 11H, H-4A, H-5A, 2 H-6B, H-5B, H-
4B, H-3B, H-2B, H-3C, H-4C, H-6’C), 3.39 (d, J = 2.7 Hz, 1H, H-5C), 3.15 (s, 3H, 
OCH3), 2.15 (s, 6H, 2 CH3CO), 1.94 (s, 12H, CH3 (NDMM)). - HRMS-Q-TOF 
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(positive mode); m/z: .1222.4551 [M + Na]. 
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Methyl 6-O-acetyl-4-O-benzyl-2,3-dideoxy-3-azido-2-dimethylmaleimido--
D-glucopyranosyl-(1 4)-3-O-acetyl-4-O-benzyl-2-deoxy-2-
dimethylmaleimido-- D-glucopyranosyl-(1 6)-2,3-dibenzyl-α-D-
galactopyranoside (29) 
 
28 (162 mg, 0.135 mmol) was dissolved in dry DCM (10 mL) under N2 
atmosphere. 3Å MS (200 mg) were added and stir for 40' at RT. Et3SiH (.ml, 
.mmol) was added, the solution cooled at -78°C and then (.ml, .mmol) TfOH was 
added dropwise. After 2h the reaction was quenched adding TEA until neutral pH 
and filtered on celite pad. The solvent was removed under reduced pressure, the 
crude was redissolved in DCM washed with a saturated solution of NaHCO3 and 
water. The organic phase was dried with sodium sulfate and the solvent removed in 
vacuo. The residue was purified by flash chromatography (n-hexane/ethyl acetate = 
6:4) to yield 29 (134 mg, 83%) as a white foam. - TLC (n-hexane/ethyl acetate 
=1:1): Rf = 0.54. - 
1
H NMR (400 MHz, CDCl3) δ 7.49 – 7.21 (m, 19H), 5.53 (dd, J 
= 10.7, 8.1 Hz, 1H), 5.10 (d, J = 8.5 Hz, 1H), 4.95 (d, J = 8.4 Hz, 1H), 4.88 (d, J = 
10.7 Hz, 1H), 4.68 – 4.48 (m, 8H), 4.41 (dd, J = 7.6, 3.9 Hz, 2H), 4.04 – 3.97 (m, 
1H), 3.96 – 3.81 (m, 3H), 3.81 – 3.68 (m, 4H), 3.62 (dd, J = 9.9, 2.9 Hz, 2H), 3.54 
– 3.42 (m, 4H), 3.39 (d, J = 2.4 Hz, 1H), 3.12 (s, 3H), 2.12 (s, 3H), 2.00 (s, 3H), 
1.91 (s, 7H). 
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Methyl 6-O-acetyl-4-O-benzyl-2,3-dideoxy-2-acetamido-3-azido--D-
glucopyranosyl-(1 4)-3,4-di-O-acetyl-4-O-benzyl-2-deoxy-2-acetamido-
D-glucopyranosyl-(1 6)-2,3-dibenzyl-α-D-galactopyranoside (30) 
 
29 (134 mg, 0.11 mmol) was dissolved in a dioxane:H2O mixture (4:1, 5ml). NaOH 
powder (220 mg, 5.5 mmol) was added and let stirred for 24h at RT. Than the pH 
was adjusted at 5 by adding 1N HCl, and the solution was stirred for other 24h. 
After completion of the reaction, it was neutralized with potassium carbonate and 
the solvent evaporated in vacuo. The residue was treated in pyridine (5mL) with 
acetic anhydride (1.1mL, 11 mmol) and stirred at RT for 24h. The solution was co-
evaporated with toluene in vacuo. The residue was purified by flash 
chromatography (dichloromethane/methanol = 98:2) to yield 30 (102 mg, 84%) as 
a white foam. - TLC (dichloromethane/methanol = 95:5): Rf = 0.34. 
 
 
 
 
 
97 
 
Methyl 6-O-acetyl-4-O-benzyl-2,3-dideoxy-2,3-diacetamido--D-
glucopyranosyl-(1 4)-3,4-di-O-acetyl-4-O-benzyl-2-deoxy-2-acetamido-- 
D-glucopyranosyl-(1 6)-2,3-dibenzyl-α-D-galactopyranoside (31) 
 
30 (102 mg, 0.09 mmol) was dissolved in dry MeOH (5 mL) under N2 atmosphere. 
Triethylamine (0.087 mL, 0.63 mmol) and 1,3-propanedithiol (0.065mL, 0.63 
mmol) were added in sequence and the solution stirred at RT for 24h. After 
completion of the reaction the solvent was removed in vacuo. The residue was 
treated in pyridine (5 mL) with acetic anhydride (0.46 mL, 4.5 mmol) and stirred at 
RT for 24h. The solution was co-evaporated with toluene in vacuo. The residue was 
purified by flash chromatography (dichloromethane/methanol = 98:2) to yield 31 
(92.5mg, 80%) as a white foam. - TLC (dichloromethane/methanol = 95:5): Rf = 
0.30. 
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Methyl (benzyl-(4-O-benzyl-2,3-diacetamido-2,3-dideoxy--D-
glucopyranosyluronate)-(1 4)-3,4-di-O-acetyl-4-O-benzyl-2-deoxy-2-
acetamido-- D-glucopyranosyl-(1 6)-2,3-dibenzyl-α-D-
galactopyranoside (32) 
 
31 (92.5mg, 0.082 mmol) was dissolved in dry MeOH (5 mL) under N2 
atmosphere. A catalytic amount of a solution 0.1M of MeONa in MeOH was 
added, and after 1h the reaction was neutralized with Amberlite IR-120. The resin 
was filtered off, and solvent evaporated in vacuo. 
The crude was dissolved in acetone (4 mL), and the solution was cooled at 0°C. 
Then were added in successively NaHCO3 5% (3.5mL), KBr (13 mg, 0.13 mmol) 
and TEMPO (16.6 mg, 0.10 mmol). After 10’ at 0°C NaClO 13% solution (0.27 
mL) was added. After 3h a TLC (DCM:MeOH=95:5) shown the disappearance of 
the starting material, and a spot at Rf=0. The solvent was removed in vacuo, 
stripping with toluene. 
The crude was redissolved in dry DMF (5mL) under N2 atmosphere and BnBr 
(0.09mL, 0.72 mmol) was added. The solution was cooled at 0°C, and KF (45 mg, 
0.37 mmol) was added, letting warmed at RT. After stirring for 16h, the solvent 
was removed in vacuo, the crude dissolved in DCM (5 mL) and washed with water 
(3 mL). The aqueous phase was extracted with DCM (3 X 5 mL). The combined 
organic layers were separated, dried with sodium sulfate and evaporated in vacuo. 
The residue was purified by flash chromatography (dichloromethane/methanol = 
98:2) to yield 19 (77mg, 79%) as a white solid. - TLC (dichloromethane/methanol 
=95:5): Rf =0.44. 
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Methyl (4-O-benzyl-2,3-diacetamido-2,3-dideoxy--D-
glucopyranosyluronate)-(1 4)-3,4-di-O-acetyl-4-O-benzyl-2-deoxy-2-
acetamido-- D-glucopyranosyl-(1 6)-2,3-dibenzyl-α-D-
galactopyranoside (33) 
 
32 (77mg, 0.064 mmol) was dissolved in MeOH:H2O=1:1 (5mL:5mL), and a 
catalytic amount of Pd/C was added. The solution was put under H2 atmosphere for 
24h. The mixture was filtered off over a Celite pad and solvent removed under 
reduced pressure to yield 13 (41mg, 100%) as a pale yellow solid. - 
1
H NMR (400 
MHz, D2O) δ 4.80 (d, J = 8.3 Hz, 1H), 4.76 (d, J = 3.8 Hz, 1H), 4.46 (d, J = 8.2 Hz, 1H), 
4.20 – 3.85 (m, 6H), 3.85 – 3.58 (m, 6H), 3.59 – 3.39 (m, 3H), 3.34 (s, 2H), 2.03 – 1.92 (m, 
7H). - 
13
C NMR (100 MHz, D2O) δ 208.29, 200.86, 188.50, 102.48, 101.86, 101.86, 99.39, 
99.39, 78.17, 78.17, 75.94, 75.94, 73.98, 70.84, 69.99, 69.40, 69.40, 68.49, 68.49, 60.80, 
55.57, 55.00, 22.23. – ESI-MS (positive mode); m/z: 656.6 [M + 1H]. 
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1
H-NMR compound 33 
 
13
C-NMR compound 33 
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Organocatalysis 
Organocatalysis uses metal-free low molecular weight organic molecules 
predominantly composed of C, H, O, N, S and P to accelerate chemical reactions. 
Most of the attention is focused on this type of molecules especially for their use in 
asymmetric catalysis, with regard to compounds of pharmaceutical interest. 
Despite the large consensus by the chemical community of the important role of 
metal catalysts in synthesis and the ongoing search for new systems, the apparent 
drawbacks cannot be ignored anymore. These include the high cost and effort for 
the preparation of the catalysts, the use of noxious metals, which, although present 
in trace amounts, contaminate the final organic product, the lack of orthogonality 
with a wide range of functional groups, and in some cases the need to operate 
under rigorously anhydrous or anaerobic conditions. 
The advent of organocatalysis brought the prospect of a complementary mode of 
catalysis, with the potential for savings in cost, time and energy, an easier 
experimental procedure, and reductions in chemical waste. These benefits arise 
from three factors. First, organic molecules are generally insensitive to oxygen and 
moisture in the atmosphere, so there is no need for special reaction vessels, storage 
containers and experimental techniques, or for ultra-dry reagents and solvents. 
Second, a wide variety of organic reagents such as amino acids, carbohydrates and 
hydroxy acids are naturally available from biological sources as single 
enantiomers. Simple organocatalysts are therefore usually cheap to prepare and 
readily accessible in a range of quantities, suitable for small-scale reactions to 
industrial-scale reactions. Third, small organic molecules are typically non-toxic 
and environmentally friendly, increasing the safety of catalysis in both biological 
and chemical research across all research settings, including industry and academic 
institutions. The combination of these factors substantially lowered the entry costs 
for researchers who were interested in developing enantioselective catalysts. With 
no need for gloveboxes, inert gases, ultra-dry solvents or even high levels of 
experimental expertise, it is not surprising that the field quickly became flooded 
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with research groups from around the globe.
1
 
The first enantioselective organocatalytic reactions had already been described at 
the beginning of the 20th century, and some astonishing, selective reactions such as 
the proline-catalyzed synthesis of optically active steroid partial structures by 
Hajos, Parrish, Eder, Sauer and Wiechert had been reported in 1971.(Scheme 1)
2 
 
Scheme 35 
After these “pioneering” works, other example of organocatalysts that have been 
very successful in asymmetric synthesis were developed and numerous research 
groups around the world are now exploring the potential of the method. A variety 
of key asymmetric carbon–carbon and carbon–heteroatom bond-forming reactions 
(such as, Diels–Alder and 1,3-dipolar cycloadditions, direct aldol condensation, 
Mannich and Michael reactions, epoxidation, hydride transfer, nitroalkane addition 
to enones, α-halogenation, and amination of aldehydes) can be carried out by using 
organocatalytic methods. 
In the framework of the asymmetric catalysis a particular class of compounds that 
has been utilized successfully in a large variety of organocatalytic transformations 
is that of thioureic organocatalyst. 
 
Fig. 6 
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They are able to accelerate and stereochemically control organic transformations 
through predominantly double hydrogen-bonding interactions with the respective 
substrate(s) (non-covalent organocatalysis). It should be noticed that most of 
these compounds have the CF3 group in their structure. Recent studies, through 
modeling and NMR experiments, demonstrated that the presence of these groups 
increase the Lewis acidity of the catalytic sites, therefore the ability to coordinate 
the substrates of the reactions, consequentely the activity of the molecule.
3
 
Jacobsen and coworkers developed a chiral thiourea (Fig.2) derivative used in 
enantioselective nucleophilic additions of HCN and ketene silyl acetals to imines 
(Strecker and Mannich reactions), obtaining good results in terms of chemical yield 
and stereoselection. This compound consists in t-leucine residue, linked with a 
derivative of 1,2-trans-diamino cyclohexane.
4 
 
Fig. 7 
The same compound and its derivatives have been successfully used also in aza-
Baylis-Hillman reactions, addition of acetophenone and acetylacetone to 
nitrostyrene and addition of diethyl malonate to imine differently substituted. 
Moreover the addition of nitroester to imine gave good results. 
For this kind of bifunctional system were hypothesized different mechanism where 
two transition states were proposed.  
In the case of neutral catalytic species (A) the thiourea group coordinates the 
carbobenzyloxy group of the imine, the basic dimethylamino group have the role to 
deprotonate the malonate and promote its addition to the carbon-nitrogen double 
bond. However, the presence of a basic group is not strictly necessary for carry out 
the reaction. In the case of a protonated form of the catalytic species it is possible 
to hypothesize a transition state B in which the amino group coordinates the 
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protonated nucleophile in its conjugated form, through hydrogen bonds in a system 
that would work only by the establishment of a network of hydrogen bonds. 
 
Fig. 8 
Another bifunctional thioureic system was developed by Takemoto and his team 
and it is shown in Fig.4.
5 
 
Fig. 9 
Also in this case a 1,2-trans-diamino cyclohexane is employed as chiral scaffold, 
bearing a tertiary amine and 3,5-bis(trifluoromethyl)phenyl thioureic group in trans 
configuration. This catalyst gave good results in different reactions, as aza-Henry, 
Michael addition, and addition of nitroalkane to imine. Since the catalysis proceed 
through the formation of hydrogen bonds, polar solvents inhibit their formation, 
decreasing the yield and the stereoselection. Best results were obtained with apolar 
solvents, in particular DCM or toluene, depending on the reaction. 
Taking into consideration the addition reaction of diethylmalonate to β-
nitrostyrene, the mechanism hypothesized proceeds through a double activation of 
both the electrophile (β-nitrostyrene) and the nucleophile (diethylmalonate), by the 
two functionalities of the molecule. As shown in Fig.5, the thioureic moiety 
interacts with the nitro group of the nitroolefin increasing its electrophilicity, while 
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the tertiary amine coordinates the enolic form of the malonate. 
 
Fig. 10 
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Carbohydrate-based organocatalyst 
Carbohydrates have been established as the most abundant and arguably the most 
structural diverse organic molecules found in nature. 
They are chiral molecules readily available in nature in a variety of diastereomeric 
forms. Their conformational rigidity provides a well defined three-dimensional 
spatial arrangement of substituents with various multi-configured hydroxyl groups 
for chemical modification. 
Furthermore, thanks to their flexibility, they are attractive as molecular scaffolds, 
both as ligands for enantioselective catalysis or themselves as metal-free catalysts, 
for their low cost, potential polyfunctionalization, and easy possibility of different 
modifications for fine tuning of steric, electronic and solubility properties. 
The first employment of carbohydrates in asymmetric homogeneous catalysis dates 
back to the early ’80, in which sugars have been used as ligands for transition 
metals. Different research groups used diphophonate moieties on saccharide 
scaffold as chiral ligand to coordinate a Rh atom. This organo-metallic compounds 
were used in hydrogenation of (Z)-α-acetamido-cinnamic acid to L-phenylalanine.6 
The first paper where a sugar was used as organocatalyst was published in 2006 
from the research group of Kunz, relying on Jacobsen work.
7
 Starting from 
glucosamine as readily accessible chiral scaffold they synthesized a library of 
catalyst, bearing different protecting group, with the ureic and the imine 
functionality in different position of the sugar. These compounds gave good results 
in asymmetric Mannich reaction. The same catalysts were used to promote Strecker 
reactions, but in this case there was a decrease of yield and e.e., probably due to the 
lower basicity of N-acyl-immine which reduced the affinity with N-H of the urea, a 
prerequisite for the reaction.(Fig.6). 
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Fig. 11 
More recently, based on the works of Takemoto and Jacobsen, different catalyst 
based on saccharide scaffold were developed to promote the addition of 
acetylacetone to nitroolefine. 
Tang in 2008 coupled a saccharide provided with an isothiocyanate in anomeric 
position with a N-[(1R,2R)-Z-aminocycloesil]-N,N-dimethylamine.(Fig.7).
8 
 
Fig. 12 
Exploiting this synthetic strategy, Shao coupled the sugar with an aminoacidic 
diamino derivative.
9
 In this case the absolute configuration of the product is 
modulated by the stereocenter of the aminoacid. In both these cases the authors 
obtained under optimize conditions good chemical yield (90 %) and e.e. of 85-
96%. (Fig.8). 
Fig. 13 
Davis and his group synthesized a series of chiral ketones derived from 
glucosamine, bearing an acetamido group in position 2, and employed these 
compound in asymmetric epoxidation of alkenes.
10
 This reaction allows to obtain 
chiral epoxide, a useful class of compounds for the pharmaceutical industry. 
Despite the conversion of the substrates were usually satisfactory, the e.e. were 
good only with some substrates, under the optimized condition.(Fig.9). 
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Fig. 14 
The research group of Peddinti in 2010 synthesized prolinamidic catalyst on a 
saccharide scaffold, starting from commercially available L-proline and D-
glucosamine, in aldol reactions, and in the asymmetric Michael addition of 
cyclohexanone to trans-β-nitrostyrene.11 The same group in 2011 developed a 
glucosamine-based primary amines as organocatalysts for the asymmetric aldol 
reaction.
12 
 
Fig. 15 
Wang and coworkers in 2010 developed a new type of sugar-based pyrrolidine 
organocatalyst, which is capable of catalyzing Michael addition reaction of ketones 
to nitrostyrenes. A remarkably better catalytic performance was provided by the 
reactions in terms of productivity (up to 98%), diastereoselectivity (syn/anti 99:1), 
enantioselectivity (up to 99%) under solvent-free reaction conditions at room 
temperature.
13
 
In a modular and more efficient approach, the sugarbased pyrrolidine is achieved 
through a click reaction, which introduces a chiral pyrrolidine moiety into a 
common and inexpensive carbohydrate. 
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Fig. 16 
Despite these compounds show a good catalytic activity, and give promising results 
usually on specific substrates, and under particolar reactions condition, the use of 
sugar as scaffold for asymmetric organocatalysis still remains under investigation 
by the scientific community. They remain attractive for the possibility to modulate 
the functional groups on the molecule. Thanks to this features, we are able to install 
different catalytic functionalities: thioureic group, amide, carbonyl groups, and 
moreover with the manipulation of the other functions of the molecule is possible 
to change the physical properties of the compounds, as the solubility, or the  
possibility to be supported on resin or silica. 
 
115 
 
Bibliography 
1
 a) C. F. Barbas III, Angew. Chem., Int. Ed., 2008, 47, 42; b) A. Dondoni and M. Massi, 
Angew. Chem., Int. Ed., 2008, 47, 4638; c) D. W. C. MacMillan, Nature, 2008, 455, 304; d) 
Chem. Rev., 2007, 107(12), special issue on organocatalysis. 
2
 a) U. Eder, G. Sauer, R. Wiechert, Angew. Chem. Int. Ed. 1971, 10, 496; b) Z. G. Hajos, D. 
R. Parrish, J. Org. Chem. 1974, 39, 1615. 
3
 Katharina M. Lippert, Kira Hof, Dennis Gerbig, David Ley, Heike Hausmann, Sabine 
Guenther, and Peter R. Schreiner, Eur. J. Org. Chem. 2012, 5919–5927. 
4
 a)Sigman, Matthew S.; Eric N. Jacobsen, Journal of the American Chemical Society 1998 
120 ,(19), 4901–4902; b) Sigman, Matthew S.; Petr Vachal, Eric N. Jacobsen, Angew. 
Chem., Int. Ed., 2000, 39 (7), 1279–1281. 
5
 Okino, Tomotaka; Yasutaka Hoashi, Yoshiji Takemoto, Journal of the American Chemical 
Society 2003, 125 (42), 12672–12673 
6
 a) W. R. Cullen, Y. Sugi, Tetrahedron Lett. 1978, 19, 1635-1636; b) R. Jackson, D. 
J.Thompson, J. Organomet. Chem. 1978, 159, C29-C31; c) R. Selke, React. Kinet. Catal. 
Lett. 1979, 10, 135-138; d) D. Sinou, G. Desiotes, React. Kinet. Catal. Lett. 1980, 14, 463-
466. 
7
 C. Becker, C. Hoben, H. Kunz, Adv. Synth. Catal. 2007, 349, 417-424. 
8
a) P. Gao, C. Wang, Y. Wu, Z. Zhou, C. Tang, Eur. J. Org. Chem. 2008, 4563-4566; b) C. 
Wang, Z. Zhou, C. Tang, Org. Lett. 2008, 10, 1707-1710. 
9
 H. Pu, P. Li, F. Peng, X. Li, H. Zhung, Z. Shao, Eur. J. Org. Chem. 2009, 4622-4626. 
10
 O. Boutureira, J. F. McGouran, R. L. Stafford, D. P. G. Emmerson, B. G. Davis, 
Org.Biomol. Chem. 2009, 7, 4285-4288. 
11
 J. Agarwal, R. K. Peddinti, Tetrahedron: Asymmetry 2010, 21, 1906-1909. 
12
 J. Agarwal, R. K. Peddinti, Tetrahedron Letters, 2011, 52, 117-121. 
13
 Lei Wang, Jie Liu, Tao Miao, Wei Zhou, Pinhua Li, Kai Ren, and Xiuli Zhang, Adv. 
Synth. Catal. 2010, 352, 2571 – 2578 
 
 
                                                 
 
 
 
 
 
 
 
 
 
 
 
116 
 
                                                                                                                            
 
 
 
 
RESULTS AND 
DISCUSSION 
 
 
 
117 
 
 
 
 
 
 
 
 
 
 
118 
 
Aim of the work 
In 2011 the research groups of Benaglia and Lay, inspired by the seminal work by 
Kunz, decided to investigate the synthesis of a new family of (thio)urea–amine 
organocatalysts on the model of Takemoto. Both catalytic residues were connected 
by an enantiomerically pure saccharide-based scaffold, as a chiral skeleton 
alternative to diamino cyclohexane. They functionalized a derivative of D-
glucosamine hydrochloride with a (thio)ureic moiety in anomeric position, and a 
tertiary, secondary or primary amine in position 2 of the sugar, while the other 
hydroxyls were differently protected. (Fig.1).
1 
 
Fig. 1 
The synthetic pathway is briefly illustrated in Scheme 1. After protection of the 
amine and acetylation of the free hydroxyls, an azide was introduced in anomeric 
position using SnCl4. After deacetylation the hydroxyls at C-3, C-4 and C-6 were 
protected, and the azide was converted in iminophosphorane through an aza-
Wittig-Staudinger reaction, which was coupled with an arylisothiocyanate to form 
the thioureic function. The final steps are the deprotection of the amine, followed 
by the conversion in a secondary or tertiary amine through reductive amination to 
afford different types of catalysts. (Scheme 1). 
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Scheme 1 
These organocatalysts were tested in different reactions as the addition of 
acetylacetone to differently substituted β-nitrostyrenes, and in Mannich reaction 
between diethyl malonate with the N-Boc imine of benzaldehyde (Scheme 2). 
 
Scheme 2 
The best results were obtained using silyl ethers as protecting groups (R=Et3Si), 
but also with acetate, benzyl, or benzylidene acetal these compounds showed an 
interesting activity. 
Preliminary experiments demonstrated the importance of the presence of a tertiary 
amine, because primary and secondary amines did not show any catalytic activity.  
A major drawback of these organocatalysts is that they are configurationally 
instable due to the presence of an anomeric emyaminal which caused easy 
anomerization leading to an α/β mixture of the catalyst. 
For these reasons it was thought to install the thiourea on a different ring position, 
maintaining the trans-diequatorial configuration of the two amino functions. Also 
in this case D-glucosamine was also employed as starting material, while the 
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tertiary amine was introduced in position 2 and the thiourea in position 3 of the 
sugar in equatorial orientation. In this way the stability of the compound is 
substantially increased. A future development could also be the inversion of the 
two catalytic sites of the molecule, as in structure B (Fig 2). 
 
Fig. 2 
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Synthetic strategy 
The retrosynthetic strategy show in Scheme 3 highlights the presence of a suitably 
protected building-block 7, provided with the two nitrogen functionality in position 
2 and 3 in trans-diequatorial configuration. The amine at C-2 is protected as 
allyloxycarbamoyl (Alloc) group, while an azide is installed at C-3. The anomeric 
position is protected with a stable group as a benzyl ether in α configuration, while 
4-OH and 6-OH are protected as a benzylidene acetal. 
Scheme 3 
The synthesis started from commercially available D-glucosamine hydrochloride. 
First the Alloc group was introduced to protect the amine. This reaction was 
performed in a biphasic solvents mixture (CHCl3-H2O). The starting material was 
first dissolved in a water solution of NaHCO3 to release the amine from the 
hydrochloride. Then a solution of allylchloroformiate in chloroform was added. 
This compound resulted contaminated by a large amount of inorganic salts, and 
therefore difficult to purify or to manipulate as a crude residue. For this reason it 
was acetylated in pyridine and acetic anhydride, chromatographically purified and 
then deacetylated to give pure compound 1 in 53% yield over 3 steps (Scheme 4).
2 
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Scheme 4 
Compound 1 was selectively benzylated in anomeric position through a Fischer 
glycosylation with BnOH and PTSA. This reaction was performed under 
thermodynamic control in order to obtain the most stable α-anomer in large 
amount. Using toluene as a solvent and heating to reflux for several hours, a 9:1 
α:β ratio was obtained. Moreover Dean-Stark apparatus was used to distil off the 
water formed during the reaction, favouring the formation of the product. The two 
anomers were easily separated by flash chromatography, and the α compound 3 
was achieved in 62% yield (Scheme 5). 
 
Scheme 5 
The next step is the protection of positions 4 and 6 as benzylidene acetal with 
benzaldehyde dimethylacetal, PTSA in chloroform under reflux. This conditions 
are employed to remove the methanol formed during the reaction by a Dean-Stark 
apparatus, to shift the equilibrium to the product 4 (Scheme 6).
3 
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Scheme 6 
The equatorial alcohol 4 was converted in the corresponding ketone 5, by oxidation 
with Dess-Martin periodinane (DMP) synthesized in our laboratory. Reduction of 
ketone 5 with NaBH4 in THF at 0°C afforded the alloside 6 in 52% yield over 2 
steps (Scheme 7). 
 
Scheme 7 
To introduce the azide in equatorial configuraton the hydroxyl group was converted 
in a good leaving group as the triflate. The subsequent reaction with sodium azide 
in moist DMF at 60°C proceeded via a SN2 mechanism providing the 2,3 
“diamino” building block 7 in 47% yield over 2 steps (Scheme 8). 
 
Scheme 8 
The subsequent steps were the transformation of the two nitrogen moiety in the 
catalytic sites of the organocatalyst. 
In a first attempt, the allyloxycarbonyl group was removed with Bu3SnH, AcOH, 
and a catalytic amount of Pd(PPh3)4 (Scheme 9). 
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Scheme 9 
The general mechanism of this reaction is illustrated in Scheme 10. Generally 
assumed for most palladium-catalyzed allylic alkylation reactions, the true catalytic 
species is believed to be the coordinatively unsaturated bis (tripheny1phosphine) 
palladium(0) complex, which is formed either by ligand dissociation from tetrakis 
(triphenylphosphine) palladium(0). This reaction proceeds thanks to Pd
II
 formed 
upon reduction by Bu3SnH. The species of Pd
II 
coordinate to the olefin of the 
carbamate, this complex can eliminate CO2 and form a secondary amine, or react 
with another moecule of hydride, regenerating the catalyst, forming propylene, 
tributhyltin carbamate. The latter treated with acid (H-X) eliminates a tributhyltin 
specie (Bu3SnX) and compound d, that decarboxylates and allows the formation of 
the free primary amine.
4 
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Scheme 10 
Product 8 wasn’t purified and used directly in the next step. As demonstrated by the 
previous work, the presence of a tertiary amine in position 2 of the sugar is 
fundamental to have a good catalytic activity of the compound. For this reason a 
reductive amination was carried out.  
First the primary amine was treated with an aqueous solution (37%) of formaline, 
to give the corresponding imine. The reduction with Na(CN)BH3, afforded the 
desired tertiary amine 9 in 42% yield (Scheme 11). 
 
Scheme 11 
The next step is the reduction of the azide with 1,3-propanedithiol to give the 
primary amine (10), which was treated with 3,5-bis-trifluoromethyl 
126 
 
phenylisothiocyanate to give the target thioureic organocatalyst 11 in 40% yield 
over 2 steps (Scheme 12). 
 
Scheme 12 
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As can be noticed from the synthetic strategy described above, the overall yield is 
not satisfactory. In order to increase the chemical yield of some crucial steps a 
second synthetic strategy was designed. 
As shown in Scheme 13, a second building-block was identified, that, unlike the 
previous one, bears a silyl group in anomeric position in β configuration. 
 
Scheme 13 
It is clear that some of the synthetic steps are similar to those described before for 
the synthesis of 11. 
Starting from 2 as common intermediate, the anomeric position was selectively 
deacetylated with a solution of hydrazine acetate in DMF, and the free OH was 
silylated with thexyl dimethyl silyl chloride to achieve 13 in 76% yield overall 
yield from glucosamine hydrochloride (Scheme 14). 
 
Scheme 14 
The treatment under Zemplen condition released the hydroxyl groups, and a 
benzylidene acetal was installed in positions 4 and 6 with benzaldehyde 
dimethylacetal and PTSA in acetonitrile at RT, providing the equatorial alcohol 14 
in 87% yield over 2 steps (Scheme 15). 
 
Scheme 15 
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The double inversion at C-3 to introduce the azide in equatorial configuration was 
performed as described above by an oxidation-reduction procedure, followed by a 
SN2 reaction. 
First the ketone 15 was synthesized with DMP and the reduction was carried out 
with NaBH(OAc)3 in a mixture of CH3CN:AcOH 1:1 at -20°C. The major steric 
hindrance of the H
-
 in this raegent allowed to obtain a higher ratio of the axial 
compound 16 in 64% yield over 2 steps. In this case the use of NaBH4 furnished an 
equimolar mixture of the two diastereoisomers 14 and 16 (Scheme 16). 
 
Scheme 16 
Unlike the previous synthetic route, the subsequent step was the removal of the 
Alloc group and the installation of the tertiary amine in the same conditions 
described before (Scheme 17). This was required because the transformation of the 
free OH in a good leaving group as a triflate or a mesylate under different 
conditions never afforded the desired products. The reaction with triflic anhydride 
and pyridine led to the degradation of the product, or the formation of the triflate in 
low amount, while the treatment with .mesyl chloride and DIPEA didn’t give any 
result and the starting material was recovered unchanged. 
 
Scheme 17 
The next step was the introduction of the azide. Also in this case the treatment with 
triflic anhydride led to the formation of byproducts, while the mesylation gave 
good results. SN2 displacement with NaN3 afforded the 2,3 “diamino” building 
block (18) in 30% yield over 2 steps (Scheme 18). 
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Scheme 18 
The thioureic moiety was introduced in compound 18 after the reduction of the 
azide with 1,3-propanedithiol and TEA, followed by the coupling with the aryl 
isothiocyanate to give the second organocatalyst 20 in 35% yield over 2 steps 
(Scheme 19). 
 
Scheme 19 
130 
 
Catalysts 11 and 20 were used as “mimicks” of the Takemoto's catalyst in Michael 
addition between acetylacetone or diethylmalonate to β-nitrostyrenes (Scheme 20). 
In preliminary catalyst test DCM or toluene were employed as solvent, and the 
reactions were carried out at RT or at 0°C, while the catalyst loading and the 
reaction time were maintained constant. 
 
Scheme 20 
The results of the test are illustrated in Table 1. 
 CAT X Solv. T Yield (%) e.e (%) 
1 11 CH3 CH2Cl2 RT >99% 73% 
2 11 CH3 CH2Cl2 0°C >99% 53% 
3 11 CH3 Tol. RT 30% 73% 
4 11 OEt CH2Cl2 RT 10% 81% 
5 20 CH3 Tol. RT -- -- 
6 20 CH3 CH2Cl2 RT -- -- 
Tab. 1 
It should be noticed that organocatalyst 11 showed a very good chemical activity in 
the conversion of acetylacetone in DCM, with a moderate enantioselection, that 
was reduced at 0°C. Furthermore the e.e was maintained in toluene as solvent, or 
using diethylmalonate as substrate, but in this two cases the chemical activity was 
much lower. 
On the contrary, catalyst 20 didn’t show any conversion of the substrate neither in 
toluene nor in DCM. 
We tried to find a convincing reason to explain the enourmously different 
bahaviour of the two catalyst. A reasonable hypothesis is that the β configuration 
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and the steric hindrance of the silyl ether impose some conformational bias to 
catalyst 20 preventing the correct and ideal coordination of the electrophile and 
nucleophile. 
A detailed computational study will be helpful to identify the preferred 
conformations of the two catalyst and to highlight their expected different mode of 
coordination of the substrates. 
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General experimental methods  
Thin Layer Chromatography  
Thin Layer Chromatography (TLC) and High Performance Thin Layer 
Chromatography (HPTLC) were performed on Merck precoated 60F254 plates 
(0.25 mm and 0.2 mm thickness, respectively). Reactions were always followed by 
TLC-analysis; compounds were visualized, when appropriate, by UV light (254 
nm) and always by spraying with:  
- Molybdic solution [21 g of (NH4)4Mo4O24, 1g of Ce(SO4)2, 31 mL of H2SO4 98%, 
970 mL water]; 
- Sulphuric acid [50 mL of H2SO4 98%, 450 mL of MeOH, 450 mL water]; 
- Ninhydrin [2.7g of 2,2-Dihydroxyindane-1,3-dione, 27 mL of AcOH, 900 mL of 
n-BuOH (or EtOH)]; 
with detection by charring at 200°C.  
 
Flash chromatography  
According to Still procedure, compounds were purified by flash chromatography, 
using Silica gel (SiO2, high-purity grade (Merck Grade 9385), pore size 60 Å, 230-
400 mesh particle size) by Sigma-Aldrich
®
. 
In some cases it was also used a flash purification system, Biotage
®
 SP1™:2 SP1 
means a single-column flash purification system [with Touch Logic Control™ and 
TLC-to-gradient feature designed to accelerate and simplify the purification 
process]. Available in sizes from 10 g to 340 g with standard (50 μm) silica, 
Biotage SNAP cartridges were used to purify our compounds. 
 
NMR analysis  
NMR spectra were recorded in a Bruker Avance 400 instrument (400, 101 MHz for 
1
H, 
13
C), and all were run at room temperature (298K) if not specified. The samples 
were prepared using deuterated solvents, as CDCl3, D2O, CD3OD and (CD3)2SO, 
137 
 
by Sigma-Aldrich
®
. 
Chemical shifts (δ) are reported in ppm scale and the coupling constants (J) in Hz. 
The chemical shift displacement is based on the residual proton in the solvent (e.g. 
the CHCl3, 0.01 % in 99.99 % CDCl3). The multiplicity of signals has been 
described as: s (singlet), d (doublet), t (triplet), m (multiplet), dd (doublet of 
doublets), dt (doublet of triplets). 
1H-NMR spectra were recorded for all the synthesized products. In the case of 
unknown structure, the characterization is here reported by 1H-NMR, 13C-NMR: 
the registration of bidimensional (2D-COSY, 2D-HETCOR) analyses was due to 
better assignment of peaks to the structure.  
In the case of a dimer we called ring-A the sugar coupled with the spacer and ring-
B the one at the non-reducing terminus. 
 
Mass analysis  
ESI mass were recorded in negative or positive modes on Jeol AX-505. 
 
HPLC analysis 
The HPLC analysis were performer with: Agilent 1100 series. The chiral 
columnn used was Daicel Chiralpak AD. 
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2-N-allyloxycarbamoyl-2-amino-2-deoxy-D-glucopyranoside (1) 
 
 
D-Glucosamine hydrochloride (10.0 g, 46.4 mmol) was dissolved in H2O (150 
mL), then NaHCO3 was added (14.8 g, 176 mmol). After 10’ a 0.4M solution of 
allylchloro formiate in CHCl3 was added dropwise. (7.3 mL in 174 mL of CHCl3). 
The biphasic solution was let vigorously stir for 24h. the solvents were evaporated 
in vacuo, and the residue was dissolved in pyridine (175 mL), and Ac2O (37.8 mL, 
360 mmol) was added. After 16h the solvent was removed in vacuo. The residue 
was dissolved in AcOEt (200 mL), and washed successively with HCl 5% (100 
mL), a saturated solution of NaHCO3 (100 mL) and water (100 mL). The organic 
phase was dried with sodium sulfate and the solvent evaporated in vacuo. The 
residue was purified by flash chromatography (Hex: AcOEt = 7:3) to yield the 
product acetylate as a solid. This one was dissolved in dry MeOH under N2 
atmosphere. A catalytic amount of t-BuOK was added, and after 1h the reaction 
was neutralized with Amberlite IR-120. The resin was filtered off, and solvent 
evaporated in vacuo to yield 1 as (6.46g, 53%). TLC 
(dichloromethane:methanol=9:1) Rf=0.37. 
The spectroscopic data were in agreement with those reported in literature
4
 
                                                 
4
 E. Kamst et al. Carbohydrate Research, 1999, 321, 176–189 
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Benzyl-2-N-allyloxycarbamoyl-2-amino-2-deoxy-α-D-glucopyranoside (2) 
 
1 (6.46 g, 24.6 mmol) was suspended in toluene (100 mL) and BnOH (30 mL, 380 
mmol). A catalytic amount of PTSA was added and the reaction was heated at 
reflux for 4h. A Dean-Stark apparatus was installed in order to eliminate the water 
formed during the reaction. The reaction was quenched with TEA, and cooled at 
RT. The solvent was evaporated in vacuo, and the residue purified by a flash 
chromatography. First the large amount of BnOH was removed with DCM as 
eluent, then the product was purified with DCM:MeOH = 95:5, to yield 2 as a 
brown solid 68% yield with an α:β ratio of 9:1.Rf = 0.39 (DCM:MeOH = 9:1) [α]D 
= 88.58 (c = 0,01 g/ml; CHCl3). - 
1
H-NMR (400 MHz, CDCl3): 7.33 (5H, m, (Ph)), 
5.90 (1H, ddd, H9, J(H9-H10) = 22.4 Hz, J(H9-H10’) = 10.7 Hz, J(H9-H8,H8’) = 
5.50 Hz), 5.50 (1H, d, NH, J(NH-H2) = 9.00 Hz), 5.25 (2H, m, H10, H10’), 4.92 
(1H, d, H1, J(H1-H2) = 3.3 Hz), 4.70 (1H, d, H7, J(H7-H7’) = 12.1 Hz), 4.56 (2H, 
47 m, H8, H8’), 4.46 (1H, d, H7’, J(H7-H7’) = 12.1 Hz), 3.94-3.56 (9H, m, H2, 
H3, H4, H5, H6, H6’, OH). - 13C-NMR (100 MHz, CDCl3): 156.97 (CO), 137.03 
(Cq(Ph)), 132.58 (C9), 128.53-127.96 (CH(Ph)), 117.98 (C10), 97.17 (C1), 73.23-
70.69 (C5, C3, C4), 69.93 (C7), 66.10 (C8), 61.62 (C6), 55.29 (C2). - ESI-HRMS 
(positive mode) m/z: 376,1366 g/mol [M + Na]. 
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Benzyl-2-N-allyloxycarbamoyl-2-amino-2-deoxy-4,6-O-benzylidene-α-D- 
glucopyranoside (3) 
 
 
2 (5.3 g, 15.0 mmol) was dissolved in CHCl3 (100 mL). PhCH(OMe)2 (3.4 mL, 
22.5 mmol) and a catalytic amount of PTSA were added A Dean-Stark apparatus 
was installed in order to eliminate the methanol formed during the reaction and the 
temperature was heated at reflux. After 2h the reaction was quenched by adding 
TEA, and cooled at RT. The solvent evaporated in vacuo, and the residue purified 
by a flash chromatography (Hex:EA = 4:1) to yield 3 as yellow solid (5.50 g, 84%) 
Rf = 0.38 (Tol:EA = 7:3) [α]D = 57.88 (c = 0,005 g/ml; CHCl3). - 
1
H-NMR (400 
MHz, CDCl3):  7.63-7.17 (10H, m, H(Ph)), 5.94 (1H, ddd, H9, J(H9-H10) = 17.2 
Hz, J(H9-H10’) = 10.9 Hz, J(H9-H8,H8’) = 5.6 Hz), 5.59 (1H, s, H11), 5.34 (1H, 
dd, H10, J(H10-H9) = 17.2 Hz, J(H10-H10’) = 1.5 Hz), 5.25 (1H, dd, H10’, 
J(H10’-H9) = 10.9 Hz, J(H10’-H10) = 1.5 Hz), 5.11 (1H, d, NH, J(NH-H2) = 5.1 
Hz), 4.98 (1H, d, H1, J(H1-H2) = 2.6 Hz), 4.76 (1H, d, H7, J(H7-H7’) = 11.9 Hz), 
4.61 (2H, d, H8, H8’, J(H8,8’-H9) = 5.6 Hz), 4.55 (1H, d, H7’, J(H7’-H7) = 11.9 
Hz), 4.27 (1H, dd, H6, J(H6-H6’) = 10.1 Hz, J(H6-H5) = 4.7 Hz), 3.98 (2H, m, 
H2,H3), 3.90 (1H, ddd, H5, J(H5-H4) = 11.6 Hz, J(H5-H6) = 8.1 Hz, J(H5-H6’) = 
4.7 Hz), 3.79 (1H, dd, H6’, J(H6’-H6) = 10.1 Hz, J(H6’-H5) = 8.1 Hz), 3.62 (1H, 
dd, H4, J(H4-H5) = 11.6 Hz, J(H4-H3) = 6.6 Hz). - 
13
C-NMR (100 MHz, CDCl3): 
136.81-134.46 (Cq(Ph)), 132.43 (C9), 129.76-126.30 (CH(Ph)), 118.18 (C10), 
102.02 (C11), 97.06 (C1), 73.83-71.48 (C3, C4, C5), 70.02 (C7), 66.22 (C8), 62.12 
(C6), 55.23 (C2). - ESI-HRMS (positive mode) m/z: 464.1791 g/mol  [M + Na] 
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Benzyl-2-N-allyloxycarbamoyl-2-amino-2-deoxy-4,6-O-benzylidene-α-D-
glucopyran-3-uloside (4) 
 
3 (5.5 g, 12.6 mmol) was dissolved  in dry DCM (30 mL) under N2 atmosphere. A 
solution of DMP (10.6 g, 25.2 mmol) in dry DCM (30 mL) was added dropwise, 
and stirred for 24h at room temperature. After completion of the reaction a 5% 
solution of thiosulfate (50 mL) was added and the mixture let stirred for 10' until 
two distinct phases were established. The organic layer was separated and washed 
with a saturated solution of NaHCO3 (50 mL), and water (50 mL). The organic 
phase was dried with sodium sulfate and the solvent evaporated in vacuo. The 
residue was purified by flash chromatography (Tol:EA = 4:1) to yield 4 as a white 
foam. (4.09 g, 74%). Rf = 0.64 (Tol:EA = 7:3) [α]D = 103.3 (c = 0,005 g/ml; 
CHCl3)  - 
1
H-NMR (400 MHz, CDCl3):  7.68-7.14 (10H, m, H(Ph)), 5.92 (1H, ddd, 
H9, J(H9-H10) = 16.2 Hz, J(H9-H10) = 10.8 Hz, J(H9-H8) = 5.6 Hz), 5.55 (2H, m, 
NH, H11), 5.42 (1H, d, H1, J(H1-H2) = 4.4 Hz), 5.34 (1H, dd, H10, J(H10-H9) = 
16.2 Hz, J(H10-H10’) = 1.1 Hz), 5.24 (1H, dd, H10’, J(H10’- H9) = 10.8 Hz, 
J(H10’-H10) = 1.1 Hz), 4.80-4.64 (2H, m, H2, H7), 4.57 (3H, m, H10, H10’, H7’), 
4.39 (1H, d, H4, J(H4-H5) = 7.8 Hz), 4.33 (1H, dd, H6, J(H6-H6’) = 10.9 Hz, 
J(H6-H5) = 4.7 Hz), 4.14 (1H, ddd, H5, J(H5-H6) = 17.0 Hz, J(H5-H6’) = 10.9 Hz, 
J(H5-H4) = 7.8 Hz), 3.94 (1H, dd, H6’, J(H6-H6’) = 10.9 Hz, J(H6’-H5) = 4.7 Hz). 
- 
13
C-NMR (100 MHz, CDCl3):  195.37 (C3), 156.33 (CO(Alloc)), 136.94-136.82 
(Cq(Ph)), 133.04 (C9), 130.42-127.04 (CH(Ph)), 118.65 (C10), 102.62 (C11), 
100.19 (C1), 83.21 (C4), 71.07 (C7), 70.02 (C6), 66.91 (C5), 66.76 (C8), 60.47 
(C2). - ESI-HRMS (positive mode) m/z: 462.1523 g/mol [M + Na]. 
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Benzyl-2-N-allyloxycarbamoyl-2-amino-2-deoxy-4,6-O-benzylidene-α-D-
allopyranoside (5) 
 
To a solution of 4 (4.09g, 9.32 mmol) in dry THF:EtOH=4:1 (20 mL: 5 mL), under 
N2 atmosphere, cooled at 0°C was added in small portion NaBH4 (517 mg, 14 
mmol). After 2h the reaction was quenched with water (20 mL) and extracted with 
DCM (2 X 30 mL) The organic phase were separated, dried with sodium sulfate 
and the solvent evaporated in vacuo. The residue was purified by flash 
chromatography (Hex:EA = 4:1) to yield 5 as a white foam. (2.87 g, 70%). Rf = 
0.56 (Tol:EA = 7:3) [α]D = -0.62 (c = 0,004 g/ml; CHCl3). - 
1
H-NMR (400 MHz, 
CDCl3): 7.68-7.22 (10H, m, H(Ph)), 5.95 (1H, ddd, H9, J(H9-H10) = 17.2 Hz, 
J(H9-H10’) = 10.8 Hz, J(H9-H8) = 5.6 Hz), 5.61 (2H, m, NH, H11), 5.34 (1H, dd, 
H10, J(H10-H9) = 17.2 Hz, J(H10-H10’) = 1.2 Hz), 5.26 (1H, dd, H10’, J(H10’-
H9) = 10.8 Hz, J(H10’-H10) = 1.2 Hz), 5.00 (1H, d, H1, J(H1-H2) = 3.9 Hz), 4.79 
(1H, d, H7, J(H7-H7’) = 11.9 Hz), 4.59 (3H, m, H7’, H8, H8’), 4.34 (1H, dd, H6, 
J(H6-H6’) = 10.2 Hz, J(H6-H5) = 5.1 Hz), 4.26 (1H, m, H3), 4.20 (1H, m, H5), 
4.01 (1H, m, H2), 3.80 (1H, m, H6’), 3.67 (1H, dd, H4, J(H4-H5) = 9.7 Hz, J(H4-
H3) = 2.6 Hz). - 
13
C-NMR (100 MHz, CDCl3): 134.40-132.61 (Cq(Ph)), 130.88 
(C9), 129.33-125.14 (CH(Ph)), 120.85 (C10), 101.41 (C11), 97.99 (C1), 79.74 
(C4), 73.47 (C7), 68.65 (C8), 68.41(C3), 62.75 (C6), 57.76 (C5), 51.92 (C2). - ESI-
HRMS (positive mode) m/z: 464.1678 g/mol [M + Na]. 
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Benzyl-2-N-allyloxycarbamoyl-2-amino-3-azido-2,3-dideoxy-4,6-O-
benzylidene-α-D-glucopyranoside (6) 
 
4 (2.87g, 6.52 mmol) was dissolved in dry DCM (25 mL) under N2 atmosphere. 
Pyridine (1.57 mL, 19.56 mmol) was added and the solution was let stir at RT for 
15'. The reaction was cooled at 0°C and triflic anhydride (1.61 mL, 9.78 mmol) 
was dropped. After 1.5 h the solution was diluted with DCM (20 mL), and washed 
with HCl 5% (30 mL), a saturated solution of NaHCO3 (30 mL) and water (30 
mL). The organic phase was dried with sodium sulfate and the solvent evaporated 
in vacuo. The crude was let for 2 h in vacuo, then dissolved in humid DMF (30 
mL). NaN3 (1.27 g, 19.56 mmol) was added and the reaction let stir at 60°C over 
night. The solvent was removed under reduced pressure, the residue redissolved in 
DCM (40 mL) and washed with water (20 mL). The organic phase were dried with 
sodium sulfate and the solvent evaporated in vacuo. The residue was purified by 
flash chromatography (Hex:EA=9:1) to yield 6 (1.42 g, 47%) as a white foam. Rf = 
0.44 (Tol:EA = 7:3) [α]D = 21.36 (c = 0,004 g/ml; CHCl3). - 
1
H-NMR (400 MHz, 
CDCl3): 7.58-7.20 (10H, m, H(Ph)), 5.95 (1H, ddd, H9, J(H9-H10) = 16.1 Hz, 
J(H9-H10’) = 10.9 Hz, J(H9-H8,H8’) = 5.7 Hz), 5.61 (1H, s, H11), 5.36 (1H, dd, 
H10, J(H10-H9) = 16.1 Hz, J(H10-H10’) = 1.2 Hz), 5.27 (1H, dd, H10’, J(H10’-
H9) = 10.9 Hz, J(H10’-H10) = 1.2 Hz), 5.08 (1H, m, NH), 4.94 (1H, d, H1, J(H1-
H2) = 3.5 Hz), 4.76 (1H, d, H7, J(H7-H7’) = 11.6 Hz), 4.61 (2H, m, H8,H8’), 4.56 
(1H, d, H7, J(H7’-H7) = 11.6 Hz), 4.26 (1H, m, H6), 3.96 (2H, m, H5, H2), 3.82 
(2H, m, H6’, H3), 3.67 (1H, t, H4, J(H4-H3,H5) = 9.4 Hz). - 13C-NMR (400 MHz, 
CDCl3): 129.09-125.96 (CH(Ph)), 118.03 (C10), 101.45 (C11), 97.23 (C1), 80.53 
(C4), 70.16 (C7), 68.87 (C6), 66.10 (C8), 63.22 (C5), 61.65 (C3), 53.81 (C2). - 
ESI-HRMS (positive mode) m/z:  489.1748 g/mol [M + Na]. 
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Benzyl-3-azido-2,3-deoxy-4,6-O-benzylidene-2-N,N-dimethylamino-α-D-
glucopyranoside (7) 
 
6 (1.17g, 3.06 mmol) was dissolved in dry DCM (25 mL) under N2 atmosphere. A 
actalytic amount of Pd(PPh3)4, glacial AcOH (0.45 mL, 7.34 mmol) and Bu3SnH 
(0.9mL, 3.36 mmol) were added in succession. The mixture was let stir at RT for 
24h. The solvent was removed under reduced pressure and the residue dried in 
vacuo. This one was redissoved in THF, then a solution of H2CO 37% in water (7.8 
mL, 107 mmol) was added and let stir for 24h. NaCN(BH)3 was slowly added and 
stirred for 2h. Then the reaction was treated with AcOH until pH = 4-5, and the 
mixture was let stir for 3h. Then the reaction was cooled at 0°C with an ice bath, 
and the pH adjusted slowly at 9 by a cold 5% solution of NaOH. Then the solution 
was extracted with AcOEt (2 X 30 mL) and the organic phase washed with brine 
(20 mL) and water (20 mL). The organic phase were dried with sodium sulfate and 
the solvent evaporated in vacuo. The residue was purified by flash chromatography 
(Hex:EA   ) to yield 7 (0.52 g, 42%) as a white foam. Rf = 0.43 (Tol:EA = 7:3) [α]D 
= 0.9 (c = 0,002 g/ml; CHCl3). - 
1
H-NMR (400 MHz, CDCl3):  7.62-7.24 (10H, m, 
H(Ph)), 5.63 (1H, s, H8), 5.11 (1H, bs, H1), 4.75 (1H, d, H7, J(H7-H7’) = 11.5 Hz), 
4.60 (1H, d, H7’, J(H7’-H7) = 11.5 Hz), 4.28 (1H, dd, H6, J(H6-H6’) = 10.2 Hz, 
J(H6-H5) = 4.8 Hz), 4.19 (1H, dd, H3, J(H3-H2) = 11.2 Hz, J(H3-H4) = 9.5 Hz), 
3.93 (1H, td, H5, J(H5-H4) = 9.9 Hz, J(H5-H6,H6’) = 4.8 Hz), 3.77 (1H, t, H6’, 
J(H6’-H5,H6) = 10.3 Hz), 3.65 (1H, t, H4, J(H4-H3,H5) = 9.4 Hz), 2.78 (1H, dd, 
H2, J(H2-H3) = 11.2 Hz, J(H2-H1) = 3.3 Hz), 2.58 (6H, s, H(Me)). - 
13
C-NMR 
(400 MHz, CDCl3): 136.98 (C(Ph)), 129.02-126.00 (CH(Ph)), 101.45 (C8), 98.22 
(C1), 81.89 (C4), 69.81 (C7), 69.13 (C6), 65.45 (C2), 63.00 (C5), 58.56 (C3), 
41.98 (CH3). - ESI-HRMS (positive mode) m/z: 433.1851 g/mol [M + Na]. 
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Benzyl-4,6-O-benzylidene-2,3-deoxi-2-N,N-dimethylamino-3-N-3,5-bis 
(trifluoromethyl-thiourea-α-D-glucopyranoside (8) 
 
7 (0.52g, 1.28mmol) was dissolved in dry MeOH (25mL) under N2 atmosphere. 
TEA (1.2mL, 8.96 mmol) and 1,3-PDT (0.9mL, 8.96 mmol) were added and the 
solution was warmed at 60°C and let stir for 24h. The reaction was cooled at RT, 
and the solvent removed in vacuo. The residue was redissolve in dry DMF (15mL), 
under N2 atmosphere. 3,5-bis (trifluoromethy) isothiocyanate (1.17ml, 6.4mmol) 
was added and the solution let stir for 24h. Then the solvent was removed in vacuo, 
and the residue was purified by flash chromatography (Tol:EA = 9:1) to yield 8 
(0.31mg, 40%) as a white foam. Rf = 0.49 (Tol:EA =7:3). - 
1
H-NMR (400 MHz, 
CDCl3): δ 7.55-7.27 (13H, m, H(Ph)), 5.54 (1H, s, H8), 4.93 (1H, d, H1 J(H1-H2) = 
3.7 Hz), 4.83 (1H, d, H7, J(H7-H7’) = 11.7 Hz), 4.59 (1H, d, H7’, J(H7’-H7) = 11.7 
Hz), 4.24 (1H, dd, H6, J(H6-H6’) = 9.9 Hz, J(H6-H5) = 4.4 Hz), 3.81 (2H, m, H4, 
H5), 3.72 (1H, t, H6’, J(H6’-H5,H6) = 10.1 Hz), 3.65 (1H, m, H3), 2.35 (1H, m, H2), 
1.27 (6H, s, H(Me)). - 
13
C-NMR (100 MHz, CDCl3): δ 172.58 (C=S), 129.09-
126.17 (CH(Ph)), 101.74 (C8), 97.48 (C1), 76.36 (C3), 69.89 (C7), 69.34 (C6), 67.66 
(C4), 64.34 (C5), 48.05 (C2), 29.70 (CH3). - ESI-HRMS (positive mode) m/z: 656.2 
g/mol [M + H]. 
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Thexyl-dimethylsilyl-3,4,6-tri-O-acetyl-2-N-allyloxycarbamoyl-2-amino-2-
deoxy-α-D-glucopyranoside (9) 
 
Hydrazine monohydrate (0.85mL, 14 mmol) was dissolved in MeOH (7mL), and 
the mixture coled at 0°C. AcOH (1.2mL, 21 mmol) was slowely added dropwise 
and the reaction was let stir at 0°C for 30'. In a second flask, the acetylated 
compound  (5.00g, 11.6 mmol) was dissolved in DMF (50mL), cooled at 0°C, and 
was added dropwise the solution of hydrazine acetate, letting warm at RT. After 2h 
the solvent was removed under reduced pressure, the residue dissolved in EA 
(100mL), and washed with a satured solution of NaHCO3 (3 X 30mL). The organic 
phases were dried with sodium sulfate and the solvent evaporated in vacuo. 
The residue was dissolved in dry DMF (50mL) under N2 atmosphere. Imidazole 
(2.36g, 34.8 mmol) was added and the temperature cooled at 0°C. Thexil-dimethyl 
silyl chloride (3.0mL, 15.1 mmol) was added dropwise and the mixture was let stir 
at RT for 16h. The solvent was removed under reduced pressure, and the residue 
redissolved in DCM (100mL), washed with water (2 X 40mL). The aquose phases 
were extracted with DCM (3 X 100mL) and the combined organic phases were 
dried with sodium sulfate and the solvent evaporated in vacuo. The residue was 
purified by flash chromatography (Hex:EA=8:2) to yield 9 (4.18g, 76%) as a white 
foam. Rf = 0.43 (Hex:EA = 7:3). 
The spectroscopic data were in agreement with those reported in literature. 
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Thexyl-dimethylsilyl-2-N-allyloxycarbamoyl-2-amino-2-deoxy-4,6-O-
benzylidene-α-D-glucopyranoside (10) 
 
9 (4.18g, 8.9mmol) was dissolved in dry MeOH (50mL) under N2 atmosphere. A 
catalytic amount of a solution 0.1M of MeONa in MeOH was added, and after 2h 
the reaction was neutralized with Amberlite IR-120. The resin was filtered off, and 
solvent evaporated in vacuo. The residue was dissolved in CH3CN (50mL) dry 
under N2 atmosphere. PhCH(OMe)2 (2.0mL, 13.35 mmol)and a catalytic amount of 
PTSA were added, and the mixture let stir at RT for 4h. The reaction was quenched 
adding TEA until neutral pH, and the solvent evaporated in vacuo. The residue was 
purified by flash chromatography (Hex:EA=8:2) to yield 10 (3.77g, 86%) as a 
white foam. Rf = 0.56 (Hex:EA = 7:3). - 
1
H-NMR (400 MHz, CDCl3): δ 7.56 – 
7.24 (m, 5H, (Ph)), 5.94 (m, J = 17.2, 10.4 Hz, 1H, H-10), 5.57 (s, 1H, (CHPh)), 
5.34 (dd, J = 17.2, 1.5 Hz, 1H, H-11), 5.28 – 5.20 (dd, 1H, H-11’), 4.85 (s, 1H, H-
1), 4.59 (dd, J = 5.7, 1.2 Hz, 2H, H-9-9’), 4.31 (dd, J = 10.5, 4.9 Hz, 1H, H-6), 3.81 
(t, J = 10.2 Hz, 1H, H-2, H-6'), 3.59 (t, J = 9.2 Hz, 1H, H-4), 3.54 – 3.45 (m, 2H, 
H3, H-5), 1.71 – 1.60 (m, 1H, H-Si), 0.95 – 0.85 (m, 12H, H-Thexil), 0.22 – 0.14 
(ss, 6H, 2 (CH3Si)). - 
13
C-NMR (100 MHz, CDCl3): δ 137.13 (C10), 127(Ph), 
117.99 (C-11), 101 (CHPh), 91.1 (C-1), 77.01 (C-6), 76.69 (s), 68.72 (C-9), 65.94 ( 
C-2, C-3,C-4, C-5), 24.82 (C-Thexyl). 
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Thexyl-dimethylsilyl-2-N-allyloxycarbamoyl-2-amino-2-deoxy-4,6-O-
benzylidene-α-D-glucopyran-3-uloside (11) 
 
 
10 (3.77g, 7.65 mmol) was dissolved  in dry DCM (30 mL) under N2 atmosphere. 
A solution of DMP (9.7g, 23 mmol) in dry DCM (30 mL) was added dropwise, and 
stirred for 24h at room temperature. After completion of the reaction a 5% solution 
of thiosulfate (50 mL) was added and the mixture let stirred for 10' until two 
distinct phases were established. The organic layer was separated and washed with 
a saturated solution of NaHCO3 (50mL), and water (50mL). The organic phase was 
dried with sodium sulfate and the solvent evaporated in vacuo. The residue was 
purified by flash chromatography (Hex:EA = 4:1) to yield 15 as a white foam. 
(2.64 g, 71%). Rf = 0.34 (Hex:EA = 7:3). - 
1
H-NMR (400 MHz, CDCl3): δ 7.56 – 
7.27 (m, 5H, (Ph)), 6.02 – 5.87 (m, 1H, H-10), 5.60 (s, 1H, CHPh), 5.35 (ddd, J = 
17.2, 3.0, 1.5 Hz, 1H, H-11), 5.25 (ddd, J = 10.4, 2.6, 1.3 Hz, 1H, H-11’), 4.77 (d, J 
= 7.4 Hz, 2H, H-9-9’), 4.67 – 4.49 (m, 2H, H-1, H-2), 4.44 (ddd, J = 11.3, 10.2, 3.1 
Hz, 2H, H4, H-6), 3.95 (t, J = 10.2 Hz, 1H, H-6’), 3.61 (td, J = 9.9, 4.9 Hz, 1H, H-
5), 1.65 (ddd, J = 16.8, 11.9, 4.9 Hz, 1H, H-Si ), 0.95 – 0.82 (m, 12H, H- Thexyl), 
0.24 – 0.14 (m, 6H, 2 (CH3Si)). 
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Thexyl-dimethylsilyl-2-N-allyloxycarbamoyl-2-amino-2-deoxy-4,6-O-
benzylidene-α-D-allopyranoside (12) 
 
15 (2.64g, 5.4 mmol) was dissolved in a mixture of CH3CN:AcOH=1:1 (50mL) 
under N2 atmosphere and the reaction cooled at -20°C in an dry ice-acetone bath. 
NaBH(OAc)3 (3.4g, 16.2 mmol) was slowely added dropwise and the mixture was 
let stir for 2h. The solvent was removed under reduced pressure, and the residue 
redissolved in DCM (50mL), washed with water (2 X 30mL). The organic phase 
was dried with sodium sulfate and the solvent evaporated in vacuo. The residue 
was purified by flash chromatography (Hex:EA = 4:1) to yield 16 as a white foam 
(2.42 g, 91%). Rf = 0.33 (Hex:EA = 7:3). - 
1
H-NMR (400 MHz, CDCl3): δ 7.62 – 
7.18 (m, 5H, (Ph)), 5.95 (ddd, J = 16.1, 10.9, 5.7 Hz, 1H, H-10), 5.61 (s, 1H, 
CHPh), 5.34 (ddd, J = 17.3, 3.1, 1.5 Hz, 1H, H-11), 5.29 – 5.18 (m, 1H, H-11’), 
4.91 (d, J = 8.0 Hz, 1H, H-1), 4.59 (d, J = 4.8 Hz, 2H, H9, H-9’), 4.36 (dd, J = 10.3, 
5.0 Hz, 1H, H-6)), 4.29 (d, J = 1.5 Hz, 1H, H-3), 3.98 (td, J = 10.0, 5.0 Hz, 1H, H-
5), 3.81 (t, J = 10.3 Hz, 2H, H-2, H-6), 3.69 (dd, J = 9.4, 2.5 Hz, 1H, H-4), 1.65 (dt, 
J = 13.7, 6.9 Hz, 1H, H-Si), 0.95 – 0.79 (m, 12H, H-Thexil), 0.18 (dd, J = 6.1, 3.0 
Hz, 6H, 2 (CH3Si)). - 
13
C NMR (100 MHz, CDCl3) δ 137.09 (C-10), 127(Ph), 117 
(C-9), 101 (CHPh), 96 (C-1), 77.33 (C-4), 79 (C-3), 69.17 (C-6), 65.5 (C-9), 62 (C-
5), 24.80 (C- Thexyl). 
150 
 
Thexyl-dimethylsilyl-2-deoxy-4,6-O-benzylidene-2-N,N-dimethylamino-α-D-
allopyranoside (13) 
 
16 (2.42g, 4.9 mmol) was dissolved in dry DCM (30mL) under N2 atmosphere. A 
catalytic amount of Pd(PPh3)4, glacial AcOH (0.67mL, 11.7 mmol) and Bu3SnH 
(1.46mL, 5.39 mmol) were added in succession. The mixture was let stir at RT for 
24h. The solvent was removed under reduced pressure and the residue dried in 
vacuo. This one was redissoved in THF, then a solution of CH2O 37% in water 
(12.7 mL, 171 mmol) was added and let stir for 24h. NaCN(BH)3 (2.5g, 39.2 
mmol) was slowly added and stirred for 2h. Then the reaction was quenched with 
AcOH until pH = 4-5, and the mixture was let stir for 3h. Then the reaction was 
cooled at 0°C with an ice bath, and the pH adjusted slowly at 9 by a cold 5% 
solution of NaOH. Then the solution was extracted with AcOEt (2 X 30 mL) and 
the organic phase washed with brine (20 mL) and water (20 mL). The organic 
phases were dried with sodium sulfate and the solvent evaporated in vacuo. The 
residue was purified by flash chromatography (DCM:MeOH=95:5) to yield 17 
(1.04g, 49%) as a white solid. Rf = 0.43 (DCM:MeOH=95:5). - 
1
H-NMR (400 
MHz, CDCl3) δ 7.59 – 7.20 (m, 5H, (Ph)), 5.58 (s, 1H, CHPh), 5.24 (d, J = 7.9 Hz, 
1H, H-1), 4.35 (m, 1H, H-6), 3.98 (dd, J = 10.0, 5.0 Hz, 1H, H-5), 3.74 (t, J = 10.3 
Hz, 2H, H-3, H-6), 3.57 (dd, J = 9.4, 2.6 Hz, 1H, H-4), 2.6 (d, J = 3.2 Hz, 6H, 2 
(NCH3)), 2.35 (dd, J = 7.9, 2.8 Hz, 1H, H-2), 1.71 (dt, J = 13.7, 6.9 Hz, 1H, H-Si), 
1.03 – 0.79 (m, 12H, H-Thexil), 0.31 – 0.09 (m, 6H, 2 (CH3Si)). - 13C NMR (100 
MHz, CDCl3): δ132.52 – 131.59 (Ph), 101.89 (CHPh),  95.38 (C-1), 79.47 (C-4), 
69.60 (C-3), 68.27 (C-6), 67.5 (C-2), 63.47 (C-5), 43.94, 33.79, 24.80 (C- Thexyl). 
- ESI-MS (positive mode) m/z: 438.4 g/mol [M + Na]. 
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Thexyl-dimethylsilyl-3-azido-4,6-O-benzylidene-2-N,N-dimethylamino-2,3-
deoxy-α-D-allopyranoside (14) 
 
17 (1.04g, 2.4 mmol) was dissolved in dry DCM (20mL) under N2 atmosphere. 
DIPEA (2.53mL, 14.4 mmol) was added and the solution let stir 15'. The 
temperature was cooled at 0°C in an ice-bath and mesyl chloride (0.56mL, 7.2 
mmol) was added dropwise. The temperature was raised at RT and the mixture let 
stir for 2h. The reaction was diluted with DCM and the organic phase washed with 
a solution of HCl 5%. The organic phase was dried with sodium sulfate and the 
solvent evaporated in vacuo. The crude was let for 2 h in vacuo, then dissolved in 
humid DMF (30 mL). NaN3 (0.47g, 7.2 mmol) was added and the reaction let stir at 
80°C over night. The solvent was removed under reduced pressure, the residue 
redissolved in DCM (40 mL) and washed with water (20 mL). The organic phase 
were dried with sodium sulfate and the solvent evaporated in vacuo. The residue 
was purified by flash chromatography (Hex:EA=9:1) to yield 18 (277 mg, 25%) as 
a white foam. Rf = 0.80 (Hex:EA = 8:2). - 
1
H-NMR (400 MHz, CDCl3): δ 7.66 – 
7.13 (m, 5H, Ph)), 5.57 (s, 1H, CHPh), 4.86 (d, J = 7.9 Hz, 1H, H-1), 4.29 (dd, J = 
10.5, 4.9 Hz, 1H, H-6), 3.73 (dt, J = 27.0, 10.2 Hz, 2H, H6', H-4), 3.51 (t, J = 9.4 
Hz, 1H, H-3), 3.37 (td, J = 9.6, 4.9 Hz, 1H, H-5), 2.60 – 2.46 (m, 7H, H-2, 2 
(NCH3)), 1.70 (dq, J = 13.9, 6.9 Hz, 1H, H-Si), 0.98 – 0.85 (m, 12H, H- Thexyl), 
0.19 (t, J = 8.0 Hz, 6H, 2 (CH3Si)). - ESI-MS (positive mode) m/z: 463.5 g/mol [M 
+ H]. 
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Thexyl-dimethylsilyl-4,6-O-benzylidene-2,3-deoxi-2-N,N-dimethylamino-3-
N-3,5-bis-(trifluoromethyl-thiourea-α-D-glucopyranoside (15) 
 
18 (277 mg, 0.6 mmol) was dissolved in dry MeOH (5 mL) under N2 atmosphere. 
TEA (0.58mL, 4.2 mmol) and 1,3-PDT (0.43mL, 4.2 mmol) were added and the 
solution was warmed at 60°C and let stir for 24h. The reaction was cooled at RT, 
and the solvent removed in vacuo. The residue was redissolve in dry DMF, under 
N2 atmosphere. 3,5-bis (trifluoromethy) isothiocyanate (0.55mL, 3.0 mmol) was 
added and the solution let stir for 24h. Then the solvent was removed in vacuo, and 
the residue was purified by flash chromatography (Tol:EA=9:1) to yield 19 (127 
mg, 30%) as a colorless oil. Rf = 0.15 (Hex:EA =9:1). - 
1
H-NMR (400 MHz, 
CDCl3): δ 7.65 – 7.11 (m, 8H, (Ph)), 5.62 (s, 1H, CHPh), 5.00 (d, J = 7.7 Hz, 1H, 
H-1), 4.36 (dd, J = 10.7, 4.9 Hz, 1H, H-6), 3.7 (t, J = 9.3 Hz, 2H, H-6, H-3), 3.60 
(t, 1H, H-4), 3.58 (m, 1H, H-5), 2.38 (m, 7H, H-2, 2 (NCH3)), 1.72 (dt, J = 13.8, 
6.9 Hz, 1H, H-Si), 0.97 – 0.89 (m, 12H, H-Thexil), 0.23 (d, J = 3.3 Hz, 6H, 2 
(CH3Si)). - 
13
C NMR (100 MHz, CDCl3) δ 198.37 (C=S), 128.86 (d, J = 38.9 Hz, 
(Ph)), 103.54 (CHPh), 96.63 (C-1), 81.74 (C-4), 69.62 (C-6), 67.15 (C-5), 56.50 
(C-3), 41.35, 33.80, 20.81 (C- Thexyl). - ESI-MS, (positive mode) m/z: 730.4 
g/mol [M + H]. 
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Catalytic tests 
All the catalytic tests were performed with a catalyst loading of 10%, for 24h, with 
1mL of solvent 1 eq. of β-nitrostyrene and 1.2 eq of acetylacetone or 
diethylmalonate were used. The products were isolated by flash chromatography 
(Hex:EA=9:1), and the e.e. was evaluated by HPLC on Chiralpak AD. As mobile 
phase was used Hex/iPrOH=85:15, with P=15bar. 
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